FR2918560A1 - Composition, useful for manufacturing products for cosmetic care of skin, lips, nails, hair, eyelashes, eyebrows and/or scalp, comprises UV filtering system, dibenzoylmethane derivative type UV-A filter and phenanthrenol compound - Google Patents

Abstract

Composition comprises at least UV filtering system, dibenzoylmethane derivative type UV-A filter and at least phenanthrenol compound (I) and their stereoisomers and/or diastereoisomers, in a cosmetically acceptable support. Composition comprises at least UV filtering system, dibenzoylmethane derivative type UV-A filter and at least phenanthrenol compound of formula (I) and their stereoisomers and/or diastereoisomers, in a cosmetically acceptable support. R 1>, R 2>, R 6>H, OH, 1-4C alkyl, 3-4C alkyl or R-OR comprising 1-3C alkyl radical; R 3>, R 4>1-3C alkyl, preferably methyl; and R 5>1-6C alkyl, preferably methyl. Provided that one of the groups R 1>, R 2> or R 6> is an OH-group and another group of R 1>, R 2> and R 6> is a linear 1-4C alkyl or branched 3-4C alkyl. [Image].

Description

COSMETIC COMPOSITION CONTAINING A UVA FILTER DERIVED FROM DIBENZOYLMETHANE

  AND PHENANTHRENOL COMPOUND; The present invention relates to a cosmetic composition containing the combination of at least one UVA filter of the type derived from dibenzoylmethane and at least one particular phenanthrenol compound of formula (I) which will be given the definition below.

  It also relates to a photostabilization process with respect to the radiation of at least one dibenzoylmethane derivative-type UVA filter by an effective amount of at least one particular phenanthrenol compound of formula (I), the definition of which will be given below. after.

  The present invention also relates to the use of at least one particular phenanthrenol compound of formula (I) in a composition comprising, in a cosmetically acceptable support, at least one UVA filter of the dibenzoylmethane derivative type in order to improve the effectiveness of said composition vis-à-vis UV-A.

  It is known that the luminous radiations of wavelengths between 280 nm and 400 nm allow the browning of the human epidermis, and that the wavelength rays more particularly between 280 and 320 nm, known under the name UV -B, cause erythema and skin burns that can affect the development of natural tanning. For these reasons as well as for aesthetic reasons, there is a constant demand for means of control of this natural tan to thereby control the color of the skin; it is therefore necessary to filter this UV-B radiation.

  It is also known that UV-A rays, with wavelengths between 320 and 400 nm, which cause browning of the skin, are capable of inducing an alteration thereof, particularly in the case of a skin sensitive or skin continuously exposed to solar radiation. UV-A rays cause in particular a loss of elasticity of the skin and the appearance of wrinkles leading to premature cutaneous aging. They promote the triggering of the erythematous reaction or amplify this reaction in some subjects and may even be the cause of phototoxic or photoallergic reactions. Thus, for aesthetic and cosmetic reasons such as the preservation of the natural elasticity of the skin for example, more and more people wish to control the effect of UV-A on their skin. It is therefore desirable to also filter the UV-A radiation.

  In order to ensure protection of the skin and keratin materials against UV radiation, it is generally used antisolar compositions comprising organic filters, active in the UV-A and active in the UV-B. Most of these filters are fat soluble.

  In this respect, a particularly interesting family of UV-A filters currently consists of the dibenzoylmethane derivatives, and in particular 4-tert-butyl-4'-methoxydibenzoylmethane, which in fact have a high intrinsic absorption capacity. These dibenzoylmethane derivatives, which are now products that are well known per se as active filters in UV-A, are described in particular in French patent applications FR-A-2326405 and FR-A-2440933, as well as in European Patent Application EP-A-0114607; 4-tert-butyl-4'-methoxydibenzoyl methane is also currently offered for sale under the trade name PARSOL 1789 8 by the company DSM NUTRITIONAL PRODUCTS.

  Unfortunately, it turns out that the dibenzoylmethane derivatives are relatively sensitive products to ultraviolet radiation (especially UV-A), that is to say, more precisely, that they have an unfortunate tendency to degrade more or less rapidly under the action of the latter. Thus, this substantial lack of photochemical stability of the dibenzoylmethane derivatives against the ultraviolet radiation to which they are inherently intended to be subjected, does not guarantee a constant protection during prolonged exposure to the sun, so that repeated applications at intervals of time Regular and close-ups must be performed by the user to achieve effective protection of the skin against UV rays.

  This technical problem has been addressed in EP1291008 patent application using a particular phenol compound 1,1,3-tris- (2-methyl-4-hydroxy-5-tert-butylphenyl) butane (RN = 1843). -03-4) such as the product sold under the trade name MIXXIM AO-30 by FAIRMOUNT CHEMICAL. However, the photostability of the dibenzoylmethane derivatives obtained and the implementation of the combination are not yet fully satisfactory.

  However, the Applicant has now discovered, surprisingly, that by associating with the dibenzoylmethane derivatives mentioned above a particular phenanthrenol compound of formula (I) which will be defined later in detail, it was possible to improve still substantially and remarkably, the photochemical stability (or photostability) of these same dibenzoylmethane derivatives and their effectiveness in UV-A. The compositions containing such an association also lead after application to a more homogeneous distribution of the UV filter.

  These findings are the basis of the present invention.

  Thus, according to one of the objects of the present invention, there is now proposed a composition comprising in a cosmetically acceptable support at least one UV filtering system, characterized in that it comprises at least: (a) at least one UV-A filter of the dibenzoylmethane derivative type and (b) at least one phenanthrenol compound of formula (I) which will be given the following definition.

  Another subject of the invention also relates to a method for improving the chemical stability with respect to the UV radiation of at least one UV-A filter of the dibenzoylmethane derivative type comprising associating with said dibenzoylmethane derivative an effective amount of at least one phenanthrenol compound of formula (I) which will be given the following definitions The present invention also finally relates to the use of at least one phenanthrenol compound of formula (I), in a composition comprising in a carrier cosmetically acceptable, an effective amount of at least one UV-A filter of the dibenzoylmethane derived type for the purpose of improving the effectiveness of said composition vis-à-vis UV-A.

  Other features, aspects and advantages of the invention will appear on reading the detailed description which follows.

  By cosmetically acceptable, is meant compatible with the skin and / or its integuments, which has a pleasant color, smell and feel and which does not generate unacceptable discomfort (tingling, tightness, redness), likely to divert the consumer to use this composition.

  An effective amount is understood to mean an amount sufficient to obtain a significant and significant improvement in the photostability of the dibenzoylmethane derivative (s) in the cosmetic composition. This minimum amount of compound of formula (I), which may vary according to the nature of the support selected for the composition, can be determined without any difficulty by means of a conventional photostability measurement test, such as that given in the examples below. -after.

  The phenanthrenol compounds according to the invention are chosen from those corresponding to the following general formula (I): in which: R 1, R 2 and R 6 denote, independently of one another, a group chosen from , OH, a C 1 -C 4 linear alkyl group, a C 3 -C 4 branched alkyl group, a -OR group with R 1 being a C 1 -C 3 alkyl group, with the proviso that one of the groups R 1, R 2 or R 6 is an OH group and another one of R 1, R 2 and R 6 is a C 1 -C 4 linear alkyl group or a C 3 -C 4 branched alkyl group; R3, R4 denote, independently of one another, a C1-C3 alkyl group, preferably a methyl group; R5 denotes a C1-C6 alkyl group, preferably a C1-C3 alkyl group, and preferably a methyl group, as well as their stereoisomers, and diastereoisomers, and mixtures thereof.

  Preferably, compounds of formula (I) are used for which R 1, R 2 and R 6 have the meaning described above; R3, R4 and R5 denote a methyl group.

  Preferably, compounds of formula (I) are used for which: R 1, R 2 and R 6 are each different and denote, independently of one another, a group chosen from OH, OH, a C 3 branched alkyl group. C4i preferably C3; R3, R4 and R5 denote a methyl group.

  Particularly preferred are the phenantrenol compounds of formula (I) for which R 1 = H; R2 = OH; R6 = isopropyl (iPr); R3, R4 and R5 denote a methyl group.

  The compounds of formula (I) can be obtained by synthesis or by extraction from raw materials of natural origin containing such compounds. Advantageously, the phenanthrenol compounds of formula (I) are chosen from: Compound NOM Chemical Abstract CAS R, R 2 R 6 R 3 R 4 R 5 1 4b, 5,6,7,8,8a, 9,10-octahydro-112867-87 ## STR1 ## , 8,8a, 9,10-octahydro-3-hydroxy-2- (1- (4-trans-4-yl) -1-methoxybeta-8,8-trimethyl-2- (1-methylethyl) -, (4bS-trans) 1- Phenanthrenol 34b, 5,6,7,8,8a, 9,10-octahydro-67119-95-3H 2 MdMuM Me Me 4b, 8,8-trimethyl-2- (1-methylethyl) -, (4bS 8aS) - 1-Phenanthrenol 4b, 5,6,7,8,8a, 9,10-octahydro-411239-21-9Hg Me Me Me 4b, 8,8-trimethyl-1- (1- methylethyl) -2-Phenanthrenol 3-ethyl-4b, 5,6,7,8,8a, 9,10- 294191-34-7 and MeOH octahydro-4b, 8,8-trimethyl-1- ( 1-methylethyl) -, (4bS, 8aS) -2H-penthenol 6b, 5,6,7,8,8a, 9,10-octahydro-130790-11H-OH-Me Me 4b, 8,8-trimethyl -1- (1-methylethyl) -, (4bS, 8aR) -2-Phenanthrenol (or cis-Totarol) 7 4b, 5,6,7,8, 8a, 9,10-octahydro-3-71629-16-8 Methoxy-4b, 8,8-trimethyl-1- (1-methylethyl) -, (4bS-trans) 2-Phenanthrenol 8b , 5,6,7,8,8a, 9,10-octahydro-3-63568-41-2-Methoxy-4b, 8,8-trimethyl-1- (1-methylethyl) trans, Me Phenanthrenol (or () -Dispermol) 9 4b, 5,6,7,8,8a, 9,10-octahydro-1857-11-0 4H, 3,8,8-trimethyl-3 - (1-methylethyl) -, (4bS, 8aS) -2-Phenanthrenol (or (+) - Sempervirol) 4b, 5,6,7,8,8a, 9,10-octahydro-17990-27-1 iPr OH Me 2 Me 4b, 8,8-trimethyl-3- (1-methylethyl) -, trans-2-Phenanthrenol (or () - Sempervirol) 11 4b, 5,6,7,8,8a, 9,10- octahydro-511-15-9H-OHMMM Me Me 4b, 8,8-trimethyl-1- (1-methylethyl) -, (4bS, 8aS) -2-Phenanthrenol (or trans-Totarol) Compound NOM Chemical Abstract CAS R, R 6 R 3 R 4 R 5 12 4b, 5,6,7,8,8a, 9,10-octahydro-4-yl, 8,8-trimethyl-2- (1- methylethyl) -, (4bR, 8aR) -3-Phenanthrenol (or Ferruquinol) 13 4b, 5,6,7,8,8a, 9,10-octahydro-1-yl-117456-91-4 OH iPr Methoxy-4b, 8,8-trimethyl-2- (1-methylethyl) -, (4bS-trans) 3-Phenanthrenol 14b, 5,6,7,8,8a, 9,10-octahydro- 4b, 8,8-trimethyl-2- (1-methylethyl) -3-phenenanthrenol 4b, 5,6,7,8,8a, 9,10-octahydro-41437 ## STR1 ## 4b, 8,8-trimethyl-2- (1-methylethyl) -, (4bR, 8aR) -rel-3-phenenanthrenol (or () -Ferruginol) 4b, 5,6,7,8,8a, 9,10-octahydro-514-62-5 ## STR1 ## 4b, 8,8-trimethyl-2- (1-methylethyl) -, (4bS, 8aS) - 3- Phenanthrenol (or (+) - Ferruginol) 18 4b, 5,6,7,8,8a, 9,10-octahydro-2-51847-85-9 OH MeP Me Me Me-4b, 8.8 trimethyl-1- (1-methylethyl) -, (4bS-trans) 3-phenanthrenol (or (+) - Dispermol) 19 4b, 5,6,7,8,8a, 9,10-octahydro-294191-33 3,4b, 8,8-tetramethyl-1- (1-methylethyl) -, (4bS, 8aS) -2-phenenanthrenol 4b, 5,6,7,8,8a, 9 , 10-octahydro- 172139-24-1 OH ## STR1 ## 4b, 8,8-trimethyl-2- (1-methylethyl) -, (4bS, 8aS) -1,3-phenanthreneediol 4b, 5,6,7,8,8a, 9,10-octahydro-84104-87-OH-1-methyl-4-methyl-1,2-trimethyl-1- (1-methylethyl) -, (4bS, 8aS) -2,3-phenanthrene-diol 23 8,11, 13-Trien-12-ol, 14-isopropyl-10395-60-5-OH-1-Me-Me Me Podocarpa 24 4b-hexyl-4b, 5,6,7,8,8a, 9,10- 108193-63-1 ## STR1 ## the compound phenol N-phenyl-N-octahydro-8,8-dimethyl-2- (1-hydroxyethylethyl) -, (4bS-trans) -3- 5,6,7,8,8a, 9,10-octahydro-8,8-dimethyl-2- (1-methylethyl) pent-4b-pentyl-, 4bS- trans) -3-yl Phenanthenol 26 4b-butyl-4b, 5,6,7,8,8a, 9,10-108193-61-9-octahydro-8,8-dimethyl-2- ( 1-butyl methylethyl) -, (4bS-trans) -3- Phenanthenol 27 4b, 5,6,7,8,8a, 9,10-octahydro-108193-60-8 OH iPr H Me n-Pr 8,8-dimethyl-2- (1-methylethyl) -4b-propyl-, (4bS-trans) 3-Phenanthrenol 4b-ethyl-4b, 5,6,7,8,8a, 9 , 10-, 108-, 108-, 59-59-5, and Me, and octahydro-8,8-dimethyl-2- (1-methylethyl) -, (4bS-trans) -3-phenenanthrenol denoting methyl; OMe designating methoxy; iPr designating isopropyl; n-Pr denoting n-propyl More preferentially, the phenanthrenol compounds of formula (I) may be chosen from: Compound NOM Chemical Abstract CAS R, R 2 R 6 R 3 R 4 R 5 14 4b, 5,6,7,8,8a, 9, 10-octahydro-112867-87-5-OH-4M, 8,8-trimethyl-1- (1-methylethyl) -, (4bR, 8aR) -rel-2-phenanthrenol (or () Totarol) 3 4b, 5,6,7,8,8a, 9,10-octahydro-67119-95-3H 4 M, 8,8-trimethyl-2- (1-methylethyl) -, (4bS, 8aS) ) 1-Phenanthrenol 4b, 5,6,7,8,8a, 9,10-octahydro-411239-21-9-OH (1-methylethyl) -2-Phenanthrenol 6 4b, 5,6,7,8,8a, 9,10-octahydro-130790-11-3H-OH-1-methyl-4-methyl-1-methyl-1-methyl-1-methyl-1-methyl-1 (4bS, 8aR) -2-Phenanthrenol (or cis-Totarol) 9 4b, 5,6,7,8,8a, 9,10-octahydro-1857-11-0 4H, m.p. 8-trimethyl-3- (1-methylethyl) -, (4bS, 8aS) -2-phenanthrenol (or (+) - Sempervirol) 4b, 5,6,7,8,8a, 9,10-octahydro-17990 4b, 8,8-trimethyl-3- (1-methylethyl) - trans -2- Phenanthrenol (or () -Servervirol) Compound NAME Chemical Abstract CAS R, R 2 R 6 R 3 R 4 R 5 11 4b, 5,6,7,8,8a, 9,10-octahydro-511-15-9H OH Me 2 Me 4b, 8,8-trimethyl-1- (1-methylethyl) -, (4bS, 8aS) -2-phenenanthrenol (or trans-Totarol) 12 4b, 5,6,7,8,8a, 9 , 4-Octahydro-4, 8,8-trimethyl-2- (1-methylethyl) -, (4bR, 8aR) -3-phenanthrenol (or ferruginol) 4b, 5-octahydro-4-aminobenzoyl; , 6,7,8,8a, 9,10-octahydro-112744-09-9 ## STR1 ## 4b, 8,8-trimethyl-2- (1-methylethyl) -3-phenenanthrenol 4b, 5, 6,7,8,8a, 9,10-octahydro-4, 8,8-trimethyl-1- (1-methylethyl) -, cis-3-phenenanthrenol 16b, 5,6,7,8,8a, 9,10-octahydro-10219-82-6HgMem Me Me 4b, 8,8-trimethyl-2- (1-methylethyl) -, (4bR, 8aR) - 3-Phenanthrenol (or () - Ferruginol) 17 4b, 5,6,7,8,8a, 9,10-octahydro-514-62-5 OH MeM Me 4b, 8,8-trimethyl- 2- (1-methylethyl) -, (4bS, 8aS) -3-Phenanthrenol (or (+) - Ferruginol) 19 4b, 5,6,7,8,8a, 9,10-octahydro- 294191-33-6 Me 3,4b, 8,8-tetramethyl-1- (1-methylethyl) -, (4bS, 8aS) 2-Phenanthrenol 23,8,11,13-trien-12-ol, 14-isopropyl-10395 More preferably, the phenanthrenol compounds of formula (I) may be chosen from: Compound NOM Chemical Abstract CAS R, R 2 R 6 R 3 R 4 R 5 1 4b, 5,6,7,8 , 8a, 9,10-octahydro-112867-87-5H-OH-1-methyl-4-methyl-1- (1-methylethyl) -, (4bR, 8aR) -rel-2-phenenanthrenol (or () Totarol) 4b, 5,6,7,8,8a, 9,10-octahydro-411239-21-9 2-Phenanthrenol 6b, 5,6,7,8,8a, 9,10-octahydro-130790-11-3-OH (1-methylethyl) -, (4bS, 8aR) -2-Phenanthrenol (or cis-Totarol) 11 4b, 5,6,7,8,8a, 9,10-octahydro-511-15-9H-OH Me Me 4b, 8.8 trimethyl-1- (1-methylethyl) -, (4bS, 8aS) -2-phenanthrenol (or trans-totarol). The compound of the following structure (I ') is more particularly preferred: t at 4b, 5,6,7,8,8a, 9,10-octahydro-4b, 8,8-trimethyl-1- (1-methylethyl) -, (4bR, 8aR) -rel-2-phenanthrenol (or () Totarol); (compound No. 1)

  In particular, it is possible to use a purified extract of Totara wood (podocarpus totara) powder obtained by supercritical CO2 extraction, sold under the name TOTAROL by the company Mende-Dek Limited; this extract contains from 50 to 65% of totarol (totara-8, 11, 13-trien-13-o1).

  The phenanthrenol compounds of formula (I) are preferably present in the composition according to the invention in a content ranging from 0.05% to 30% by weight, relative to the total weight of the composition, and preferably ranging from 0, 1 to 20% by weight.

  Among the derivatives of dibenzoylmethane, mention may be made, in a nonlimiting manner: 2-methyldibenzoylmethane, 4-methyldibenzoylmethane, 4-isopropyldibenzoylmethane, 4-tert.-butyldibenzoylmethane, 2015 - 2 , 4-dimethyldibenzoylmethane, 2,5-dimethyldibenzoylmethane, 4,4'-diisopropyldibenzoylmethane, 4,4'-dimethoxydibenzoylmethane, s-4-tert-butyl-4'-methoxydibenzoylmethane, 2- methyl-5-isopropyl-4'-methoxydibenzoylmethane, 2-methyl-5-tert-butyl-4'-methoxydibenzoylmethane, 2,4-dimethyl-4'-methoxydibenzoylmethane, 2,6-dimethyl-4 -tert-butyl-4'-methoxydibenzoylmethane. Among the dibenzoylmethane derivatives mentioned above, use will in particular be made of 4-isopropyl-dibenzoylmethane, sold under the name "Eusolex 8020" by the company Merck, and corresponding to the following formula:

  It is particularly preferred to use 4- (tert-butyl) -4'-methoxy dibenzoylmethane or Butyl Methoxy Dibenzoylmethane, sold for sale under the trade name "PARSOL 1789" by the company DSM NUTRITIONAL PRODUCTS; this filter has the following formula:

  The derivative (s) of dibenzoylmethane may be present in the compositions according to the invention at contents which preferably vary from 0.01 to 10% by weight and more preferably from 0.1 to 6% by weight relative to to the total weight of the composition.

  The compositions in accordance with the invention may comprise, in addition to other water-soluble or liposoluble, or otherwise insoluble UVA and / or UVB UV-screening agents in the commonly used cosmetic solvents.

  Of course, those skilled in the art will take care to choose the optional additional filters and / or their amounts in such a way that the advantageous properties intrinsically attached to the compositions in accordance with the invention are not, or not substantially, impaired. by the addition or additions envisaged in particular the improvement of the photostability of the dibenzoylmethane derivative.

  The additional organic photoprotective agents are in particular chosen from anthranilates; cinnamic derivatives; salicylic derivatives, camphor derivatives; benzophenone derivatives; 13,13-diphenylacrylate derivatives; triazine derivatives; benzotriazole derivatives; benzalmalonate derivatives including those cited in US5624663; benzimidazole derivatives; imidazolines; bis-benzoazolyl derivatives as described in patents EP669323 and US 2,463,264; p-aminobenzoic acid derivatives (PABA); methylene bis- (hydroxyphenylbenzotriazole) derivatives as described in US5,237,071, US 5,166,355, GB2303549, DE 197 26 184 and EP893119; benzoxazole derivatives as described in patent applications EP0832642, EP1027883, EP1300137 and DE10162844; filter polymers and silicone filters such as those described in particular in the application WO-93/04665; alkyl-styrene-derived dimers such as those described in patent application DE19855649; 4,4-diarylbutadienes as described in Applications EP0967200, DE19746654, DE19755649, EP-A-1008586, EP1133980 and EP133981 and mixtures thereof.

  As examples of complementary organic photoprotective agents, mention may be made of those designated below under their INCI name: Derivatives of para-aminobenzoic acid: PABA, Ethyl PABA, Ethyl Dihydroxypropyl PABA, Ethylhexyl Dimethyl PABA sold in particular under the name ESCALOL 507 by ISP, Glyceryl PABA, PEG-25 PABA sold under the name UVINUL P25 by BASF,

  Salicylic derivatives: Homosalate sold under the name Eusolex HMS by Rona / EM Industries, Ethylhexyl Salicylate sold under the name Neo Heliopan OS by Haarmann and Reimer, Dipropylene glycol salicylate sold under the name DIPSAL by SCHER, TEA Salicylate, sold under the name NEO HELIOPAN TS by Haarmann and Reimer, cinnamic derivatives: Ethylhexyl Methoxycinnamate sold in particular under the trade name Parsol MCX by Hoffmann La Roche, Isopropyl Methoxy Cinnamate, Isoamyl Methoxy Cinnamate sold under the trade name NEO HELIOPAN E 35 1000 by HAARMANN and REIMER, Cinoxate, DEA Methoxycinnamate, - Diisopropyl Methylcinnamate, Glyceryl Ethylhexanoate Dimethoxycinnamate 40 Derivatives of 13,13-diphenylacrylate Octocrylene sold in particular under the trade name UVINUL N539 by BASF, Etocrylene, sold in particular under the trade name UVINUL N35 by BASF,

  Benzophenone Derivatives: Benzophenone-1 sold under the trade name UVINUL 400 by BASF, Benzophenone-2 sold under the trade name UVINUL D50 by BASF Benzophenone-3 or Oxybenzone, sold under the trade name UVINUL M40 by BASF, 50 Benzophenone- 4 sold under the trade name UVINUL MS40 by BASF, Benzophenone-5 Benzophenone-6 sold under the trade name Helisorb 11 by Norquay Benzophenone-8 sold under the trade name Spectra-Sorb UV-24 by American Cyanamid Benzophenone-9 sold under the name commercial UVINUL DS-49 by BASF, n-hexyl benzophenone-12 2- (4-diethylamino-2-hydroxybenzoyl) -benzoate sold under the trade name UVINUL A + or in admixture with octylmethoxycinnamate under the trade name UVINUL A + B by BASF.

  Derivatives of benzylidene camphor: 3-Benzylidene camphor manufactured under the name MEXORYL SD by CHIMEX, 4-Methylbenzylidene camphor sold under the name EUSOLEX 6300 by MERCK, Benzylidene Camphor Sulfonic Acid manufactured under the name MEXORYL SL by CHIMEX, Camphor Benzalkonium Methosulfate manufactured under the name MEXORYL SO name by CHIMEX, Terephthalylidene Dicamphor Sulfonic Acid manufactured under the name MEXORYL SX by CHIMEX, Polyacrylamidomethyl Benzylidene Camphor manufactured under the name MEXORYL SW by CHIMEX, Derivatives of phenyl benzimidazole: Phenylbenzimidazole Sulfonic Acid sold in particular under the trade name Eusolex 232 by Merck, Disodium Phenyl Dibenzimidazole Tetrasulfonate sold under the trade name NEO HELIOPAN AP by Haarmann and Reimer, derivatives of phenyl benzotriazole: Drometrizole Trisiloxane sold under the name Silatrizole by Rhodia Chimie, Methylene bis-Benzotriazolyl Tetramethylbutylphenol, sold in solid form under the name commercial MIXXIM BB / 100 by FAIRMOUNT CHEMICAL or in micronized form in aqueous dispersion under the trade name TINOSORB M by CIBA SPECIALTY CHEMICALS,

  Triazine derivatives: Bis-Ethylhexyloxyphenol Methoxyphenyl Triazine sold under the trade name TINOSORB S by CIBA GEIGY, Ethylhexyl triazone sold in particular under the trade name UVINUL T150 by BASF, Diethylhexyl Butamido Triazone sold under the trade name UVASORB HEB by SIGMA 3V, 40 2 , 4,6-tris (dineopentyl 4'-amino benzalmalonate) -s-triazine 2,4,6-tris- (4'-amino benzalmalonate diisobutyl) -s-triazine, symmetrical triazine filters described in the patent US6,225,467, WO2004 / 085412 (see compounds 6 and 9) or Symetrical Triazine Derivatives IP.COM Journal, IP.COM INC. WEST HENRIETTA, NY, US (September 20, 2004) including 2,4,6 -tris- (biphenyl) -1,3,5-triazines (especially 2,4,6-tris (biphenyl-4-yl-1,3,5-triazine) and 2,4,6-tris ( terphenyl) -1,3,5-triazine which are included in patent applications WO06 / 035000, WO06 / 034982, WO06 / 034991, WO06 / 035007, WO2006 / 034992, WO2006 / 034985.

  Anthranilic Derivatives: Menthyl anthranilate sold under the trade name NEO HELIOPAN MA by Haarmann and REIMER,

  Imidazoline Derivatives: Ethylhexyl Dimethoxybenzylidene Dioxoimidazoline Propionate, Benzalmalonate Derivatives: Di-neopentyl 4'-methoxybenzalmalonate Polyorganosiloxane with benzalmalonate functions such as Polysilicone-15 sold under the trade name PARSOL SLX by HOFFMANN LA ROCHE

  4,4-Diarvlbutadiene derivatives: 1,1-dicarboxy (2,2'-dimethylpropyl) -4,4-diphenylbutadiene

Benzoxazole Derivatives: 2,4-bis- [5-1 (dimethylpropyl) benzoxazol-2-yl- (4-phenyl) imino] -6 (2-ethylhexyl) imino-1,3,5-triazine sold under the name of Uvasorb K2A by Sigma 3V and mixtures thereof.

  Preferred complementary organic photoprotective agents are chosen from ethylhexyl methoxycinnamate homosalate ethylhexyl salicylate, octocrylene, phenylbenzimidazole sulphonic acid, benzophenone-3, benzophenone-4, benzophenone-5, 2- (4-diethylamino-2-hydroxybenzoyl) benzoate. n-hexyl. 4-Methylbenzylidene camphor, Terephthalylidene Dicamphor Sulfonic Acid, Disodium Phenyl Dibenzimidazole Tetrasulfonate, Methylene bis-Benzotriazolyl Tetramethylbutylphenol Ethylhexyl triazone, Bis-Ethylhexyloxyphenol Methoxyphenyl Triazine Diethylhexyl Butamido Triazone, 2,4,6-Tris (4'-amino benzalmalonate dineopentyl) 2,4,6-tris (diisobutyl 4'-aminobenzalmalonate) -s-triazine. 2,4,6-tris (biphenyl-4-yl-1,3,5-triazine) 2,4,6-tris (terphenyl) -1,3,5-triazine Drometrizole Trisiloxane Polysilicone-15 Di- neopentyl 4'-methoxybenzalmalonate 40 1,1-dicarboxy (2,2'-dimethyl-propyl) -4,4-diphenylbutadiene 2,4-bis- [5-1 (dimethylpropyl) benzoxazol-2-yl- (4-phenyl) ) -imino] -6 (2-ethylhexyl) imino-1,3,5-triazine and mixtures thereof.

  The inorganic photoprotective agents are chosen from coated or uncoated metal oxide pigments (average size of the primary particles: generally between 5 nm and 100 nm, preferably between 10 nm and 50 nm), for example, sodium oxide pigments. titanium (amorphous or crystallized in rutile and / or anatase form), iron, zinc, zirconium or cerium which are all UV 50 photoprotective agents well known per se.

  The pigments can be coated or uncoated.

  The coated pigments are pigments which have undergone one or more surface treatments of a chemical, electronic, mechanochemical and / or mechanical nature with compounds as described, for example, in Cosmetics & Toiletries, February 1990, Vol. 105, p. 53-64, such as amino acids, beeswax, fatty acids, fatty alcohols, anionic surfactants, lecithins, sodium, potassium, zinc, iron or aluminum salts of fatty acids, metal alkoxides (titanium or aluminum), polyethylene, silicones, proteins (collagen, elastin), alkanolamines, silicon oxides, metal oxides or sodium hexametaphosphate.

  In known manner, the silicones are organosilicon polymers or oligomers with a linear or cyclic, branched or crosslinked structure, of variable molecular weight, obtained by polymerization and / or polycondensation of suitably functionalized silanes, and essentially constituted by a repetition of main motifs in which the silicon atoms are connected to each other by oxygen atoms (siloxane bond), optionally substituted hydrocarbon radicals being directly bonded via a carbon atom to said silicon atoms.

  The term "silicones" also includes the silanes necessary for their preparation, in particular alkyl silanes.

  The silicones used for coating the pigments suitable for the present invention are preferably chosen from the group containing alkyl silanes, polydialkylsiloxanes, and polyalkylhydrogensiloxanes. Even more preferentially, the silicones are chosen from the group containing octyl trimethyl silane, polydimethylsiloxanes and polymethylhydro-genosiloxanes.

  Of course, the metal oxide pigments before their treatment with silicones, may have been treated with other surfactants, in particular with cerium oxide, alumina, silica, aluminum, silicon compounds, or mixtures thereof.

  The coated pigments are more particularly titanium oxides coated with: - silica such as the product "Sunveil" from the company IKEDA and the product "Eusolex TAVO" from the company MERCK - silica and iron oxide such as the product "SUNVEIL F" from IKEDA, - silica and alumina such as "MICROTITANIUM DIOXIDE MT 500 SA" and "MICROTITANIUM DIOXIDE MT 100 SA" products from the company TAYCA, "TIOVEIL" from the company TIOXIDE, and Mirasun TiW 60 from Rhodia, - alumina such as the products "TIPAQUE TTO-55 (B)" and "TIPAQUE TTO-55 (A)" from ISHIHARA, and "UVT 14/4" from KEMIRA aluminum alumina and stearate such as the product "MICROTITANIUM DIOXIDE MT 100 TV, MT 100 TX, MT 100 Z, MT-01 from the company TAYCA, the products" Solaveil CT-10 W "," Solaveil CT 100 "and" Solaveil CT 200 "from the company UNIQEMA, - silica, alumina and alginic acid such as the product" MT-100 AQ "from the company TAYCA, - alumina e aluminum laurate such as the product "MICROTITANIUM DIOXIDE MT 100 S" from the company TAYCA, iron oxide and iron stearate such as the product "MICROTITANIUM DIOXIDE MT 100 F" from the company TAYCA, zinc oxide and zinc stearate such as the product "BR351" from the company TAYCA, silica-alumina and treated with a silicone such as the products "MICROTITANIUM DIOXIDE MT 600 SAS", "MICROTITANIUM DIOXIDE MT 500 SAS "or" MICROTITANIUM DIOXIDE MT 100 SAS "from TAYCA, - silica, alumina, aluminum stearate and treated with a silicone such as the product" STT-30-DS "from TITAN KOGYO of silica and treated with a silicone such as the product "UV-TITAN X 195" from KEMIRA, or the product SMT-100 WRS from TAYCA. of alumina and treated with a silicone such as the products "TIPAQUE TTO-55 (S)" from ISHIHARA, or "UV TITAN M 262" from KEMIRA, of triethanolamine such as the product "STT-65- S "of the company TITAN KOGYO, - stearic acid such as the product" TIPAQUE TTO-55 (C) "from the company ISHIHARA, - sodium hexametaphosphate such as the product" MICROTITANIUM DIOXIDE MT 150 W "of the TAYCA company.

  Other titanium oxide pigments treated with a silicone are preferably TiO 2 treated with octyl trimethyl silane and whose average elementary particle size is between 25 and 40 nm, such as that sold under the trade name "T 805 "by the company Degussa Silices, the TiO 2 treated with a polydimethylsiloxane and whose average elementary particle size is 21 nm, such as that sold under the trade name" 70250 Cardre UF TiO2S13 "by CARDRE, TiO2 anatase / rutile treated with a polydimethylhydrogensiloxane and whose average elementary particle size is 25 nm, such as that sold under the trade name "MICRO TITANIUM DIOXIDE USP GRADE HYDROPHOBIC" by the company COLOR TECHNIQUES.

  Uncoated titanium oxide pigments are for example sold by the company Tayca under the trade names "MICROTITANIUM DIOXIDE MT 500 B" or "MICROTITANIUM DIOXIDE MT600 B", by the company DEGUSSA under the name "P 25", by the WACKHER company under the name "transparent titanium oxide PW", by MIYOSHI KASEI under the name "UFTR", by TOMEN under the name "ITS" and by the company TIOXIDE under the name "TIOVEIL AQ".

  The uncoated zinc oxide pigments are, for example, those marketed under the name "Z-cote" by the company Sunsmart; those marketed under the name "Nanox" by the company Elementis; those marketed under the name "Nanogard WCD 2025" by Nanophase Technologies;

  The coated zinc oxide pigments are, for example, those sold under the name Z-COTE HP1 by the company 40 Sunsmart (ZnO coated with dimethicone); those marketed under the name "Zinc Oxide CS-5" by the company Toshibi (ZnO coated with polymethylhydrogenosiloxane); those marketed under the name "Nanogard Zinc Oxide FN" by the company Nanophase Technologies (as a 40% dispersion in Finsolv TN, benzoate of C12-C15 alcohols); -Those sold under the name "DAITOPERSION ZN-30" and "DAITOPERSION Zn-50" by the company Daito (dispersions in cyclopolymethylsiloxane / polydimethylsiloxane oxyethylenated, containing 30% or 50% of zinc nano-oxides coated with silica and polymethylhydrogensiloxane ); Those marketed under the name "NFD Ultrafine ZnO" by the company Daikin (ZnO coated with perfluoroalkylphosphate and copolymer based on perfluoroalkylethyl dispersed in cyclopentasiloxane); those marketed under the name "SPD-Z1" by Shin-Etsu (ZnO coated with silicone-grafted acrylic polymer, dispersed in cyclodimethylsiloxane); those marketed under the name "Escalol Z100" by the company ISP (ZnO treated alumina and dispersed in the mixture methoxycinnamate ethylhexyl / copolymer PVP-hexadecene / methicone); those marketed under the name "Fuji ZnO-SMS-10" by the company Fuji Pigment (ZnO coated with silica and polymethylsilsesquioxane); those marketed under the name "Nanox Gel TN" by Elementis (ZnO dispersed at 55% in C12-C15 alcohols benzoate with hydroxystearic acid polycondensate).

  Uncoated cerium oxide pigments are sold for example under the name "COLLOIDAL CERIUM OXIDE" by the company RHONE POULENC. Uncoated iron oxide nanopigments are for example sold by ARNAUD under the names "NANOGARD WCD 2002 (FE 45B)", "NANOGARD IRON FE 45 BL AQ", "NANOGARD FE 45R AQ," NANOGARD WCD 2006 ( FE 45R) ", or by the company MITSUBISHI under the name" TY-220 ".

  The coated iron oxide pigments are for example sold by ARNAUD under the names "NANOGARD WCD 2008" (FE 45B FN) "," NANOGARD WCD 2009 (FE 45B 556) "," NANOGARD FE 45 BL 345 "," NANOGARD FE 45 BL ", or by the company BASF under the name" OXIDE OF CLEAR IRON ".

  Mention may also be made of mixtures of metal oxides, in particular titanium dioxide and cerium dioxide, including the titanium dioxide / silica-coated cerium-aluminum alloy mixture sold by the company IKEDA under the name "SUNVEIL A". ", as well as the mixture of titanium dioxide and zinc dioxide coated with alumina, silica and silicone such as the product" M 261 "sold by the company KEMIRA or coated with alumina, silica and glycerin such as that the product "M 211" sold by KEMIRA.

  The additional photoprotective agents are generally present in the compositions according to the invention in proportions ranging from 0.01% to 20% by weight relative to the total weight of the composition, and preferably ranging from 0.1% to 10% by weight relative to the total weight of the composition. relative to the total weight of the composition.

  According to one particular form, the compositions may contain at least one additional light-stabilizing agent for the dibenzoylmethane derivatives.

  By way of example of additional light-stabilizing agent, those selected from (1) arylalkyl benzoate compounds; (2) amidated oils; (3) eutectic mixtures of n-butylphthalimide and isopropylphthalimide; (4) compounds capable of accepting triplet excited level energy of said dibenzoylmethane derivative (5) 1,1,3-tri- (2-methyl-4-hydroxy-5-tert-butylphenyl) butane; (6) siloxane phenol or bis-phenol compounds (7) non-silicone phenol or bis-phenol compounds (8) non-silicone amides or arylalkyl esters (9) or arylalkyl siloxane amides or esters ( 10) their mixtures. (1) Aralkyl benzoate compounds. Those of the formula (II) where X is O, S or N; n is an integer of 1 to 10 and more preferably of 2 to 6; R 'and R2, identical or different, denote a hydrogen atom; the hydroxyl group; a linear or branched C1-C4 alkoxy radical (preferably methoxy or ethoxy); the nitro radical; the amino radical; the radical C6H6SO2.

  The arylalkyl benzoate derivatives in accordance with the invention and their syntheses have been known for a long time in the chemical literature and in particular in patent PL55230.

  Among the arylalkyl benzoate derivatives mentioned above, there will be used more particularly 2-ethylphenyl benzoate such as the commercial product X-TEND 226 8 sold by the company ISP. (2) Amidated oils

  The term "amidated oil" will be understood throughout the text of the description as any compound comprising in its chemical structure at least one amide group (or function) of the type: ## STR5 ## and simultaneously having the following characteristics: a) liquid at 25 ° C., b) insoluble or immiscible with water at 25 ° C. c) does not have emulsifying properties. 15 20 25

  In particular, those of formula (IIIa) or (IIIb) ## STR2 ## will be chosen in particular those of formula (IIIa) or (IIIb) ## STR1 ##

  In which: the radical R 3 represents a monovalent, saturated or unsaturated, aliphatic, cycloaliphatic or cyclic hydrocarbon radical, optionally functionalized, containing from 1 to 30 carbon atoms, preferably from 1 to 22 carbon atoms, inclusive; the radicals R4, R5 and R6, which may be identical or different, represent hydrogen or monovalent, saturated or unsaturated, aliphatic, cycloaliphatic or cyclic hydrocarbon radicals, optionally functionalized, containing from 1 to 30 carbon atoms, preferably from 1 to 22 carbon atoms, inclusive; q is an integer from 0 to 2.

  Examples of aliphatic saturated hydrocarbon radicals that may be mentioned include linear or branched, substituted or unsubstituted, C1-C30, preferably C1-C22, alkyl radicals, and in particular methyl, ethyl, n-propyl and isopropyl radicals. , n-butyl, isobutyl, tert-butyl, pentyl, n-amyl, isoamyl, neopentyl, n-hexyl, n-heptyl, n-octyl, 2-ethylhexyl, tert-octyl, decyl, lauryl and octadecyl. As examples of cyclic saturated hydrocarbon radicals, there may be mentioned cyclopentyl and cyclohexyl radicals, optionally substituted, in particular with alkyl radicals. Examples of aliphatic unsaturated hydrocarbon radicals that may be mentioned include substituted or unsubstituted C 2 -C 30, preferably C 2 -C 22, linear or branched alkenyl or alkynyl radicals, and especially vinyl, allyl, oleyl and linoleyl radicals.

  Examples of cyclic unsaturated hydrocarbon radicals which may be mentioned include aryl radicals such as phenyl and naphthyl, which are optionally substituted, in particular with alkyls, for example the tolyl radical, and as examples of unsaturated cycloaliphatic radicals, mention may be made more particularly of benzyl and phenylethyl radicals. Functionalized radicals more particularly include radicals comprising in their chemical structure, both in the main chain and on a secondary chain, one or more functional groups of the type, in particular esters, ethers, alcohols, amines, amides and ketones, but preferably esters. Preferred amidated oils of formula (IIIa) or (IIIb) are chosen from those in which: R 4 (IIIa) (IIIb) R 3 represents a linear or branched C 1 -C 22 alkyl radical; a C2-C22 alkenyl radical, linear or branched; an aryl radical; R4 represents a hydrogen atom or a linear or branched C1-C6 alkyl group; R5 represents a hydrogen atom or a linear or branched C1-C6 alkyl group; R 6 represents a linear or branched C 1 -C 10 alkyl radical, or a linear or branched C 2 -C 10 alkenyl radical or a sterol residue.

  In the formula (IIIa) or (IIIb) presented above, the group R 3 (CO) - is an acyl group of an acid chosen preferably from the group formed by acetic acid, toluic acid, capric acid, lauric acid, myristic acid, palmitic acid, stearic acid, behenic acid, linoleic acid, linolenic acid, oleic acid, isostearic acid, 2-ethylhexanoic acid, coconut oil fatty acids, palm kernel oil fatty acids. These acids may further have a hydroxyl group.

  In the formula (IIIa), when p is 1, the -N (R 4) CH (R 5) (CH 2) q (CO) - part of the amino acid ester is preferably chosen from those corresponding to the following amino acids: glycine alanine, valine, leucine, isoleucine, serine, threonine, proline, hydroxyproline, B-alanine, N-butyl B-alanine, aminobutyric acid, aminocaproic acid, sarcosine, or N-methyl-B-alanine.

  In the formula (IIIa), when p is 1, the part of the amino acid esters corresponding to the group OR6 can be obtained from the alcohols chosen from the group formed by methanol, ethanol, propanol, isopropanol, butanol, tert-butanol, isobutanol. , 3-methyl-1-butanol, 2-methyl-1-butanol, pentanol, hexanol, cyclohexanol, octanol, 2-ethylhexanol, decanol, lauryl alcohol, myristic alcohol, cetyl alcohol, cetostearyl alcohol, stearyl alcohol, oleic alcohol, alcohol behenyl alcohol, jojoba alcohol, 2-hexadecyl alcohol, 2-octyldodecanol alcohol and isostearyl alcohol.

  The oils having in their structure at least one amide function of formula (III) according to the invention are known per se. Some are described in particular with their methods of preparation in the patent applications EP 1 044 676 and EP 0 928 608 from the company AJINOMOTO CO. Others are known in cosmetics as repellents such as N-acetyl N-butylaminopropionate or N, N-diethyl-toluamide.

  Among the compounds of formula (IIIa) or (IIIb) that are particularly preferred are: (1) N-acetyl N-butylaminopropionate of the following formula: trademark Repellent R3535 by the company MERCK;

  (2) isopropyl N-lauroylsarcosinate of the formula: ## STR5 ## such as the product sold under the name ELDEW SL-205 by the company Ajimoto. (3) N, N-diethyl toluamide of the formula: ## STR2 ## such as the product sold under the trade name DEET by the company Showa Denko.

  The oil or oils having in their structure at least one amide function as defined above are present in the compositions according to the invention at concentrations ranging preferably from 0.1 to 40% by weight and more preferably from 1 to 20% by weight. % by weight relative to the total weight of the composition.

  (3) eutectic mixtures of n-butylphthalimide and isopropylphthalimide

  The eutectic mixtures according to the invention preferably consist of: (a) 60 to 75% by weight of n-butyphthalimide of the following structure (2): O (b) 25 to 40% by weight of isopropylphthalimide according to The invention corresponds to the following structure (3): (3) The eutectic mixtures n-butylphthalimide / isopropylphthalimide according to the invention are known and are described and synthesized in US Pat. No. 6,306,373 (forming an integral part of the content of the description) .

  Among the eutectic mixtures that can be used, mention may be made of the following mixtures: n-butylphthalimide / isopropylphthalimide (60/40% by weight) n-butylphthalimide / isopropylphthalimide (62/38% by weight) n-butylphthalimide / isopropylphthalimide (65/35% by weight) n-butylphthalimide / isopropylphthalimide (70/30% by weight) n-butylphthalimide / isopropylphthalimide (75/25% by weight)

  For example, the eutectic mixture n-butylphthalimide / isopropylphthalimide sold under the name PELEMOL BIP by Phoenix Chemicals will be used.

  The eutectic mixture according to the invention will preferably be used at concentrations ranging from 0.1 to 40% by weight and more preferably from 1 to 30% by weight relative to the total weight of the composition.

  (4) Compounds capable of accepting triplet excited level energy of said dibenzovlmethane derivative. In a preferred form, compounds capable of accepting triplet excited level energy of said dibenzoylmethane derivative have a triplet excited level energy of from 40 kcal / mol to 70 kcal / mol.

  The excited triplet level energies can be determined by oxygen disturbance or phosphorescence techniques as described in the article by J. Gonzenbach, TJ Hill, TG Truscott The Triplet Energy Levels in UVA and UVB Sunscreens, J. Photochem. Photobiol. B: Biol, Vol 16, pp. 337-379 (1992). The oxygen perturbation technique consists in measuring the UV absorption spectrum of a compound when it is placed in an environment under high oxygen pressure: ie 2000 psi. Under these conditions, the spin selection rules are disturbed and the exposure of the compound to the UV leads to the lowest triplet excited level by direct excitation of the ground state. The wavelength (in m) at which the transition occurs is used to calculate the energy of the triplet level in kcal / mol by the formula E = 28.635 / X which is derived from the equation E = hv where E is the energy, h the Planck constant and v the frequency of the electromagnetic wave.

  The phosphorescence technique is based on the fact that many compounds emit phosphorescence upon deactivation of their excited triplet level. By measuring the wavelength at which phosphorescence occurs, the triplet energized energies can be calculated as before. The excited triplet level energies can be determined by measuring the phosphorescence spectra of samples with a spectrophotometer equipped with a phosphorescence accessory. Such excited triplet levels have been widely reported for example in the article by A.J. Gordon, R.A. Ford, The Chemist Companion, John Wiley & Sons, pp. 351-355 (1992).

  The compounds of the triplet excited level of said dibenzoylmethane derivative are, for example, chosen from: (i) naphthalene derivatives such as those described in patents US 5993789, US6113931, US6126925, US 6284916; (ii) 4-hydroxy-benzylidene malonate derivatives or 4-hydroxycinnamate derivatives such as those described in WO03 / 007906; (iii) fluorene derivatives as described in patent applications US200400579912, US200400579914, US200400579916, US2004062726; (iv) piperidinol salts such as those described in the patent application WO03 / 103622; (v) their mixtures.

  Among the naphthalene derivatives according to the invention, use is more particularly Diethylhexyl 2,6-Naphthalate (INCI name) as the product sold under the trade name HALLBRITE TQ by C.P. HALL.

  Among the 4-hydroxy-benzylidene malonate derivatives or the 4-hydroxycinnamate derivatives, use will more particularly be made of the compound Diethylhexyl Syringylidenemalonate (INCI name) of the following formula: O MeO HO O OME such as the commercial product sold under the name Oxynex ST 10 by Merck.

  Among the fluorene derivatives, the polymer of the following structure will be used more particularly: with t = 1 and u is a number from 2 to 10. Among the piperidinol salts, use will be made more particularly of the compound Tris (tetramethylhydroxypiperidinol) citrate with structure: H ~

  H3C H3 with y = 3 such as the commercial product TINOGUARD S-FX by CIBA-GEIGY. The compounds capable of accepting the energy of the triplet state of the dibenzoylmethane derivatives in accordance with the invention may be present in the compositions in accordance with the invention at contents ranging from 0.1 to 25% by weight and more. preferably from 0.2 to 10% by weight and even more preferably from 0.2 to 7% by weight relative to the total weight of the composition. ## STR2 ##

  HOCHO COO-1 CH 2 COO COO sold the name TINOGUARD Q or 5 (5) 1,1,3-tri- (2-methyl-4-hydroxy-5-tert-butylphenyl) butane of the following formula: H3C as the commercial product sold under the trade name MIXXIM AO 30 by FAIRMOUNT CHEMICAL.

  The compound 1,1,3-tri- (2-methyl-4-hydroxy-5-tert-butylphenyl) butane is preferably present in the composition of the invention in proportions ranging from 0.1% to 15%. % by weight and more preferably from 0.2 to 10% by weight, relative to the total weight of the composition. (6) The siloxane phenol or bis-phenol compounds In particular, those having the following general formula (IV) or (V) will be selected: ## STR2 ## (V) in which: R7, which may be identical or different, denote hydrogen, a C1-C4 alkyl radical or two adjacent R7 radicals may together form a C5-C7 ring, R8 denotes: a hydrogen atom a linear or branched C1-C20i alkyl radical which may contain at least one substituent chosen from a C5-C7 carbon ring, an oxygen, nitrogen, sulfur or silicon atom; a C 1 -C 20 alkenyl radical; an alkylaryl radical C1-C20, R9, which may be identical or different, represent a C1-C20 alkoxy radical which may be substituted by at least one oxygen or silicon; a linear or branched C1-C20 alkyl or hydroxyalkyl which may contain at least at least one substituent chosen from a C 5 -C 7 carbon ring, an oxygen, nitrogen, sulfur or silicon atom, a C 1 -C 20 alkenyl radical; a C 7 -C 20 alkylaryl radical, optionally substituted on the aryl part by at least one hydroxyl or C 1 -C 4 alkoxy, two adjacent R 9 radicals can together form a C 5 -C 7 ring optionally substituted by at least one oxygen atom; m is 0.1 or 2, n is 0, 1, 2 or 3, pest or 1, A is the linker between the two aromatic rings and may be a direct link, a methylene, mono- or di-substituted group. by a C1-C4 alkyl radical, a sulfur atom or an oxygen atom; with the proviso that when p = 1, R7 and R8 are different from hydrogen and R9 in the ortho position with respect to the OH function, then R9 is different from a ter-alkyl radical (for example ter-butyl). R, which may be identical or different, represent a linear or branched and optionally halogenated C 1 -C 20 alkyl radical, a C 6 -C 12 aryl radical, 3,3,3-trifluoropropyl, trimethylsilyloxy or a C 1 -C 10 alkoxy group, a = 0 to 3, B is a divalent radical chosen from the group corresponding to one of the following formulas (VI), (VII) or (VIII):

  CH2ùCH ù (Z) vùW CH - CH ù (Z) v ù IIH2

  In which: Z is a linear or branched, saturated or unsaturated C 1 -C 6 alkylene radical optionally substituted by a hydroxyl radical or a linear or branched, saturated or unsaturated C 1 -C 18 alkyl radical, W represents a hydrogen atom, a hydroxyl radical or a linear or branched, saturated or unsaturated, C1-C18 alkyl radical, 45 vest0 or 1, or 1 or more. In addition to the units of formula -Bu (Si) (R) a ( 0) (3_a) 2i the organosiloxane may comprise units of formula (R) b- (Si) (O) (4-b) / 2 in which: R has the same meaning as in formulas (IV) and ( V), (VIII) b = 1.2 or 3, Preferably, the groups û (Si) (R) a (O) (3a) / 2 may be represented by the following formula (IX) or (X) : Rio Rio Rio Rio (D) ùSiûO + SiûO Jr [SiûO-Siù (D) Rio Rio (C) Rio RR 10 io O-Si] t [O-Si Rio (E) in which: (E) is binding between the silicone chain and the group B of the phenols of formulas (IV) to (V), R10, which are identical or different, are chosen from linear or branched C1-C20 alkyl, phenyl, 3,3,3-trifluoropropyl and trimethylsilyloxy radicals, at least 80% by number of the radicals R10 being methyl, (D), which are identical or different, and chosen from the radicals R10 and the radical (E), r is an integer between 0 and 200 inclusive, and s is an integer between 0 and 50 inclusive, and if s = 0, at least one of the two symbols (D) denotes B, u is an integer between 1 and 10 inclusive, and t is an integer from 0 to 10 inclusive, with the proviso that t + u is equal to or greater than 3, with the proviso that when q is 1, then u is equal to 1, s equals 1 and the symbol (D) can not denote B or s equals 0 and only one of the symbols (D) denotes B.

  In the formulas (IV) to (X), among the alkyl groups, mention may especially be made of methyl, ethyl, n-propyl, isopropyl, n-butyl, isobutyl, tert-butyl and 2-ethylhexyl groups. dodecyl or hexadecyl.

  The linear or cyclic diorganosiloxanes of formula (IX) or (X) falling within the scope of the present invention are random oligomers or polymers preferably having at least one, and even more preferably all of the following characteristics: R 10 is preferably methyl, - (D) is preferably methyl (in the case of linear compounds of formula (IX).) By way of examples of compounds of formula (IV) which are particularly preferred, mention may be made of the compounds of formula (a) to ( n): ## STR5 ## where: ## STR1 ## or ## STR1 ## where ## STR2 ## (RN = 242469-40-5) (RN = 242469-44-9) (b) (c) (d) OH (e) (RN = 119401-59-1) ) OH (RN = 21698-00-0) HO (g) 6 m statistic = 6 (i) 10 ùSiùO + iiùO 1m [SiùO n sta tistic = 2.1 m statistic = 12.5 HO (m) (n) As examples of compounds of formula (V) which are particularly preferred, mention will be made of the following compounds of formula (o) to (w): O 0 (o) (RN = 58567-01-4) (RN = 225235-10-9) (p) O (q) (RN = 208931-14-0) (r) OH (s) O OH The compounds of formula (IV) can be obtained conventionally by carrying out a hydrosilylation reaction from a siloxane derivative of formula ## STR2 ## (XII) (in which for example all (E) are hydrogen atoms, this derivative is hereinafter referred to as SiH) and an unsaturated derivative of formula (XI) or (X111) according to the following reaction scheme: Si) ùO (3-a) / 2 I (R) a (Z), + Hù (Si) ùO (3a) / 2. (IV) (R) to (R9) n (X111) (XII)

  wherein the radicals R, R7, R8, R9, Z and W, and a, n, p and v have the meaning of the formulas above. SiH groups may be present in the chain and / or at the ends of the chain. These SiH derivatives are well known products in the silicone industry and are generally commercially available. They are described, for example, in US Pat. No. 3,220,972, US Pat. No. 3,697,473 and US Pat. No. 4,340,709. (V) OH W (R 9) n (XI) R 7 OH + (Z) to 20

  In the same way, the compounds of formula (V) can be obtained according to the following reaction scheme: ## STR2 ## ## STR2 ## The compounds of formula (IV) and (V) ## STR2 ## ) according to the invention are preferably present in the compositions according to the invention at contents of 0.01 to 20% by weight and more preferably of 0.1 to 10% and even more preferentially of 0.1 to 5% by weight. % by weight relative to the total weight of the composition. (7) Non-silicone phenols or bis-phenols compounds More particularly, those having the following general formula (XIV) or (XV) will be chosen: +] q (XIV) (R 13) n (XV) in which: R 11, which are identical or different, denote hydrogen, a C 1 -C 4 alkyl radical or two adjacent R 11 may together form a C 5 -C 7 ring, R 12 denotes: - a hydrogen atom, - a linear C 1 -C 20 alkyl radical or branched may contain at least one substituent selected from a carbon ring C5-C7, an oxygen atom, nitrogen, sulfur or silicon; a C 1 -C 20 alkenyl radical; a C 1 -C 20 alkylaryl radical, which may be identical or different, represent a C 1 -C 20 alkoxy radical which may be substituted by at least one oxygen or silicon; a linear or branched C1-C20 alkyl or hydroxyalkyl which may contain at least one substituent chosen from a C5-C7 carbon ring, an oxygen, nitrogen, sulfur or silicon atom, an C1-alkenyl radical; -C20; a C 7 -C 20 alkylaryl radical, optionally substituted on the aryl part by at least one hydroxyl or C 1 -C 4 alkoxy, two adjacent R 13 radicals can together form a C 5 -C 7 ring optionally substituted by at least one oxygen atom; m is 0.1 or 2, n is 0, 1, 2 or 3, pest or 1, A is the linker between the two aromatic rings and may be a direct link, a methylene, mono- or di-substituted group. by a C1-C4 alkyl radical, a sulfur atom or an oxygen atom; with the proviso that when p = 1, R 11 and R 12 are different from hydrogen and R 13 in the ortho position with respect to the OH function, then R 13 is different from a ter-alkyl radical (for example tert-butyl).

  In the formulas (XIV) and (XV), among the alkyl groups, there may be mentioned especially the methyl, ethyl, n-propyl, isopropyl, n-butyl, isobutyl, tert-butyl, 2-ethylhexyl, dodecyl groups. or hexadecyl. Among the compounds of formula (XIV), the following compounds (a ') to (I') will be used: (BHA, RN = 121-00-6) (RN = 4979-46-8) (RN = 18403-57-1) ii (Eugenol, RN = 97-53-0) (RN = 96-76-4) (RN = 2772-45-4) OH (RN = 14938-35-3) OH ii (RN = 210154-52-2) OH, - 1. (NR = 114450-81-6) OH Zingerol, (RN = 39728-80-8) Among the compounds of formula (XV), there will be used more particularly the compounds (m ') to (z'), (aa) , (ab) and (ab): Magnolol, RN = 528-43-8 OH, R N = 1806-29-7 Magnolol, RN = 528-43-8 OH Honokiol, NR = 35364-74-6 OH OH Dehydrodieugenol, RN = Magnolignan, RN = 20601-85-8 OH HO (d) RN = 65355-00-2 1035 (RN = 85-60-9) (RN = 119-47-1) = 88-24-4) (RN = 77-62-3) (RN = 79-96-9) (t OH (RN = 32113-46-5) OH (RN = 96-66-2) (RN) = 1745-89-7) OH (NR = 96-69-5) OH (z ') (aa) (ab) OH (RN = 109348-07-4) Compounds of formula (XIV) and (XV) in conformity according to the invention are preferably present in the compositions in accordance with the invention at contents of from 0.01 to 20% by weight and more preferably from 0.1 to 10% and even more preferentially from 0.1 to 5% by weight. weight relative to the total weight of the composition (8) Non-silicone amides or arylalkyl esters

  In particular, those having the following general formulas (XVI), (XVII), (XVIII) will be chosen: ## STR2 ## (R 14) a 4 / a (XVI) O IIII (CH 2) m Wherein R14 is a linear or branched C1-C4 alkyl radical, wherein R14 is a linear or branched C1-C4 alkyl radical; -aest0-2, - m is 0-4, - b is 1 or 2, - R15 is H, a linear or branched C1-C20 alkyl, or the acetyl group, - R16 is independently H or methyl, -pest0-4, -gest0-3, -X is O, NH or NR18, -Y is CH or N, -R17 and R18 are linear or branched C1-C20 alkyl radicals, with the following condition for the formula (XVIII): if Y = CH, R16 = H, m = 0, p = 2, then a is different from 0 and R14 different from methyl.

  In formulas (XVI), (XVII) and (XVIII), among the alkyl groups, there may be mentioned in particular methyl, ethyl, n-propyl, isopropyl, n-butyl, isobutyl, tert-butyl, ethyl 2 hexyl, dodecyl or hexadecyl.

  Among the amide compounds of formula (XVI), the following compounds (a ") to (k") will be used more particularly: RN = 3278-14-6 RN = 73355-77-830 NH RN = 3271-81-6 NH RN = 10264-31-0 RN = 152328-83-1 RN = 154319-75-2 RN = 18859-20-6 (f ") G") RN = 154319-75-2 Among the amide compounds of formula (XVII), use will be made more particularly of the following compounds (I ") to (r"): embedded image RN = 1776-56-3 NH "N '---- O RN = 315711-63-8 RN = ## STR1 ## Among the arylalkyl ester compounds of formula (XVIII) mentioned above, will use more particularly the following compounds (s ") to (f"): RN = 89291-00-9 RN = 726-26-1 RN = 758717-16-7 o 15 RN = 71653-43-5 The ester compounds of formulas (XVIII) can be prepared by reacting the acid derivative of formula (XIX) with the alcohol of formula (XX) in the presence of an acid catalyst such as, for example, concentrated sulfuric acid in a solvent medium such as, for example, tolueneaccording to the following scheme: (R 14) aO (CH 2) m "OH] b + b HO-OH R 16 Y (R 14) a (XVIII) (XIX) (XX) with the radicals R 14 R 16 1 a, b, m and p having the same meaning as above. The amide compounds of formula (XVI) can be prepared by reacting the acid chloride of formula (XXI) with the amine ester of formula (XXII) in the presence of an HCl sensor such as for example triethylamine in a a solvent medium, for example acetonitrile, according to the following scheme: ## STR2 ## with the radicals R 14 R 15 meaning only above.

  The amide compounds of formula (II) can be prepared by reacting the acid derivative of formula (XXIII) with the alcohol of formula (XXIV) in the presence of an acidic catalyst such as concentrated sulfuric acid in a solvent medium. for example, toluene according to the following scheme: ## STR2 ## (II) ## STR2 ##

  The amide compound (s) or arylalkyl ester (s) may be present in the compositions at levels which are generally between 0.01% and 20% by weight, and preferably at levels of between 0.1% and 10% by weight. weight, based on the total weight of the composition.

  (9) Amides or esters of arylalkyl siloxanes

  We will choose more particularly those corresponding to the following general formulas (XXV):

  The siloxane arylalkyl ester or amide derivatives according to the invention are chosen from those corresponding to the following general formula (I): ## STR5 ## (F 2) in which - R19 is a linear or branched C1-C4 alkyl radical, -pest0-2, - m is 0-4, X is O or -N (R20) - - R20 is H, C1-C4 alkyl; C20, linear or branched, the acetyl group or the group -CH 2 CH 2 NH (C = O) Ph, (XXV II) Toluene 30 -R, which may be identical or different, represent a linear or branched C 1 -C 20 alkyl radical, an aryl radical, 06-012, 3,3,3-trifluoropropyl, trimethylsilyloxy or a linear or branched C 1 -C 10 alkoxy group, a = 1-2, B is a divalent radical selected from the group corresponding to one of the following formulas (VI), (VII) or (VIII): ## STR5 ## wherein Z is embedded in the formula (VI), (VII) or (VIII); a linear or branched, saturated or unsaturated C1-C6 alkylene radical, which may be substituted killed by a hydroxyl radical or a linear or branched, saturated or unsaturated C 1 -C 8 alkyl radical, W represents a hydrogen atom, a hydroxyl radical or a linear or branched, saturated or unsaturated C 1 -C 6 alkyl radical, vest0ou 1. In addition to the units of formula -Bu (Si) (R) a (O) (3_a) 2i, the organosiloxane may comprise units of formula (R) b- (Si) (O) (41b) / 2 in which: R has the same meaning as in formula (I) defined above, b = 2-3. Preferably, the groups û (Si) (R) a (O) (3a) / 2 may be represented by the following formulas (XXVI) or (XXVII): RR 21 21 R21 R21

  (D) -Si-O - [- Si-O Jr [Si-O-Si- (D) (XXIX) R21 R21 (E) R21 or 21 R21 -Si] 1 [O Si] u R21 (E) (XXX) in which: (E) is a binder between the silicone chain and the group B of the compound of formula (I) as defined above, R21, which may be identical or different, are chosen from linear or branched C1-C20 alkyl radicals, phenyl, 3,3,3-trifluoropropyl and trimethylsilyloxy, at least 80% by number of the radicals R3 being methyl, (D), which are identical or different, are chosen from the radicals R21 and the radical (E), r is a whole number between 0 and 200 inclusive, and s is an integer between 0 and 50 inclusive, and if s = 0, at least one of the two symbols (D) denotes B, u is an integer between 1 and 10 inclusively, and t is an integer between 0 and 10 inclusive, with the proviso that t + u is equal to or greater than 3, with the proviso that when q is 1, then u is 1, s is 1 and the symbol (D) can not denote B or s equals 0 and only one of the symbols (D) denotes B.

  In the formulas (XXV) to (XXX), among the alkyl groups, mention may especially be made of methyl, ethyl, n-propyl, isopropyl, n-butyl, isobutyl, tert-butyl, 2-ethylhexyl, dodecyl or hexadecyl groups.

  The linear or cyclic diorganosiloxanes of formula (XXIX) or (XXX) falling within the scope of the present invention are oligomers or random polymers preferably having at least one, and even more preferably all of the following characteristics: R21 is preferably methyl, - (D) is preferably methyl (in the case of linear compounds of formula (XXIX)).

  By way of examples of compounds of formula (XXV) which are particularly preferred, mention may be made of the compounds of formula (a) to (k ") as follows: ## STR5 ## b ,, if / \ S

  ## STR2 ## ## STR2 ## ## STR2 ## ## STR2 ## ## STR1 ## Si Si (Si + Si / Si / SiO Si Si Si Si Si Si / Si-O / OO Si Si / Si0 OO Sig '1 + The amide derivatives of formulas (XXV) with X = -NH- can be prepared starting from the acid derivative of formula (XXXI) with in situ formation of the corresponding acid chloride which is reacted with the siloxane amine derivative of formula (XXXII) according to the following scheme: ## STR2 ## or CICOCOCI (R 1) p (R) a (XXXI I) (XXV)

  with the radicals R, R19i p, m, a and B having the same meanings as above.

  The ester derivatives of formulas (XXV) with X = -O- can be obtained conventionally by carrying out a hydrosilylation reaction from a siloxane derivative of formula (XXXIII) (in which for example all (E) are hydrogen atoms, this derivative is hereinafter referred to as SiH) and an unsaturated derivative of formula (XXIV) or (XXXV) according to the following reaction scheme: ## STR2 ## R) a (XXV) (R19) p Li c-where Z) v + (XXXIII) + H14Si) ùO (3-a) / 2 '(XXV)) (R) a (XXXIII)

  in which the radicals R, R 19, Z, W, a, n, p and v have the same meanings as the formulas above.

  SiH groups may be present in the chain and / or at the ends of the chain. These SiH derivatives are well known products in the silicone industry and are generally commercially available. They are described, for example, in US Pat. Nos. 3,220,972, 3,697,473 and 4,340,709.

  The compounds of formula (XXV) according to the invention are preferably each present in the compositions at contents of 1 to 30% by weight and more preferably from 3 to 20% by weight relative to the total weight of the composition.

  The compositions according to the invention may also contain agents for artificial tanning and / or browning of the skin (self-tanning agents), and more particularly dihydroxyacetone (DHA). They are preferably present in amounts ranging from 0.1 to 10% by weight relative to the total weight of the composition. (XXX IV) OH (XXXV) The aqueous compositions in accordance with the present invention may furthermore comprise conventional cosmetic adjuvants, chosen in particular from fatty substances, organic solvents, ionic or nonionic thickeners, hydrophilic or lipophilic thickeners, softeners, humectants, opacifiers, stabilizers, emollients, silicones, antifoams, perfumes, preservatives, anionic, cationic, nonionic, zwitterionic or amphoteric surfactants, actives, fillers, polymers, propellants, alkalinizing or acidifying agents or any other ingredient usually used in the cosmetic and / or dermatological field.

  The fatty substances may consist of an oil or a wax other than the apolar waxes as defined above or mixtures thereof. By oil is meant a liquid compound at room temperature. By wax is meant a compound which is solid or substantially solid at ambient temperature and whose melting point is generally greater than 35 C.

  As oils, mention may be made of mineral oils (paraffin); vegetable (sweet almond oil, macadamia oil, blackcurrant seed oil, jojoba oil); synthetic such as perhydrosqualene, alcohols, fatty amides (such as isopropyl lauroyl sarcosinate sold under the name of Eldew SL-205 by Ajinomoto), fatty acids or esters, such as C12-C15 alcohols benzoate; sold under the trade name Finsolv TN or Witconol TN by the company WITCO, 2-ethylphenyl benzoate as the commercial product sold under the name X-TEND 226 8 by the company ISP, octyl palmitate, isopropyl lanolate triglycerides, including those of capric / caprylic acids, dicaprylyl carbonate sold under the name Cetiol CC by Cognis), oxyethylenated or oxypropylenated esters and fatty ethers; silicone oils (cyclomethicone, polydimethylsiloxane or PDMS) or fluorinated oils, polyalkylenes, trialkyl trimellitates such as tridecyl trimellitate.

  As waxy compounds, mention may be made of carnauba wax, beeswax, hydrogenated castor oil, polyethylene waxes and polymethylene waxes, such as that sold under the name Cirebelle 303 by the company SASOL.

  Among the organic solvents, mention may be made of lower alcohols and polyols. These can be selected from glycols and glycol ethers such as ethylene glycol, propylene glycol, butylene glycol, dipropylene glycol or diethylene glycol.

  As hydrophilic thickeners, mention may be made of carboxyvinyl polymers such as Carbopols (Carbomers) and Pemulen (acrylate / C10-C30-alkylacrylate copolymer); polyacrylamides, for example crosslinked copolymers sold under the names Sepigel 305 (CTFA name: polyacrylamide / C13-14 isoparaffin / Laureth 7) or Simulgel 600 (CTFA name: acrylamide / sodium acryloyldimethyltaurate copolymer / isohexadecane / polysorbate 80) by the company Seppic ; polymers and copolymers of 2-acrylamido-2-methylpropanesulphonic acid, optionally cross-linked and / or neutralized, such as poly (2-acrylamido-2-methylpropanesulphonic acid) marketed by Hoechst under the trademark Hostacerin AMPS (CTFA name: ammonium polyacryloyldimethyl taurate or SIMULGEL 800 sold by the company SEPPIC (CTFA name: sodium polyacryolyldimethyl taurate / polysorbate 80 / sorbitan oleate); copolymers of 2-acrylamido-2-methylpropanesulphonic acid and hydroxyethyl acrylate such as SIMULGEL NS and SEPINOV EMT 10 sold by the company SEPPIC, cellulosic derivatives such as hydroxyethylcellulose, polysaccharides and in particular gums such as Xanthan gum, and mixtures thereof.

  As lipophilic thickeners, mention may be made of synthetic polymers such as poly C 10 -C 30 alkyl acrylates sold under the name INTELIMER IPA 13-1 and INTELIMER IPA 13-6 by the company Landec, or modified clays such as hectorite and its derivatives. derivatives, such as the products marketed under the names of Bentone.

  Among the active ingredients, mention may be made of: vitamins (A, C, E, K, PP) and their derivatives or precursors, alone or in mixtures, anti-pollution agents and / or anti-radical agents; depigmenting agents and / or pro-pigmenting agents; anti-glycation agents; the soothing agents; the NO-synthase inhibitors; agents stimulating the synthesis of dermal or epidermal macromolecules and / or preventing their degradation; agents stimulating the proliferation of fibroblasts; agents stimulating the proliferation of keratinocytes; - muscle relaxants; tensing agents, mattifying agents, keratolytic agents, desquamating agents; the moisturizing agents; anti-inflammatory agents; agents acting on the energetic metabolism of cells; insect repellents; antagonists of substances P or CRGP. - anti-hair loss and / or hair regrowth agents - anti-wrinkle agents.

  Of course, those skilled in the art will take care to choose the optional additional compound (s) mentioned above and / or their amounts in such a way that the advantageous properties intrinsically attached to the compositions in accordance with the invention are not, or substantially, not, altered by the addition or additions envisaged, in particular the improvement of the photostability of the derivative of dibenzoylmethane.

  The compositions according to the invention can be prepared according to the techniques well known to those skilled in the art. They may be in particular in the form of an emulsion, simple or complex (O / W, W / O, O / W / H or W / O / W) such as cream, milk or cream gel ; in the form of an aqueous gel; in the form of a lotion. They may optionally be packaged in aerosol and be in the form of foam or spray.

  Preferably, the compositions according to the invention are in the form of an oil-in-water or water-in-oil emulsion.

  The emulsions generally contain at least one emulsifier chosen from amphoteric, anionic, cationic or nonionic emulsifiers, used alone or as a mixture. The emulsifiers are suitably selected according to the emulsion to be obtained (W / O or O / W). The emulsions may also contain other types of stabilizers, for example fillers, gelling or thickening polymers.

  As emulsifying surfactants that may be used for the preparation of W / O emulsions, mention may be made, for example, of alkyl esters or ethers of sorbitan, of glycerol or of sugars; silicone surfactants such as dimethicone copolyols such as the mixture of cyclomethicone and dimethicone copolyol, sold under the name DC 5225 C by Dow Corning, and alkyl dimethicone copolyols such as Laurylmethicone copolyol sold under the name Dow Corning 5200 Formulation Aid "by Dow Corning; cetyl dimethicone copolyol such as the product sold under the name Abil EM 90R by Goldschmidt and the mixture of cetyl dimethicone copolyol, polyglycerol isostearate (4 moles) and hexyl laurate sold under the name ABIL WE 09 by the company Goldschmidt. One or more coemulsifiers may also be added, which advantageously may be selected from the group consisting of alkylated polyol esters.

  Polyol alkyl esters that may especially be mentioned include polyethylene glycol esters such as PEG-30 dipolyhydroxystearate, such as the product marketed under the name Arlacel P135 by the company ICI; Examples of glycerol and / or sorbitan esters that may be mentioned are polyglycerol isostearate, such as the product sold under the name Isolan GI 34 by the company Goldschmidt; sorbitan isostearate, such as the product sold under the name Arlacel 987 by the company ICI; sorbitan isostearate and glycerol, such as the product sold under the name Arlacel 986 by the company ICI, and mixtures thereof.

  For O / W emulsions, mention may be made, for example, as emulsifiers, of nonionic emulsifiers such as oxyalkylenated (more particularly polyoxyethylenated) fatty acid esters of glycerol; oxyalkylenated fatty acid and sorbitan esters; oxyalkylenated fatty acid esters (oxyethylenated and / or oxypropylenated) such as the PEG-100 Stearate / Glyceryl Stearate mixture marketed for example by the company ICI under the name Arlacel 165; oxyalkylenated fatty alcohol ethers (oxyethylenated and / or oxypropylenated); sugar esters such as sucrose stearate; fatty alcohol and sugar ethers, in particular alkylpolyglucosides (APG) such as decylglucoside and laurylglucoside sold, for example, by Henkel under the respective names Plantaren 2000 and Plantaren 1200, cetostearylglucoside optionally mixed with cetostearyl alcohol; , marketed for example under the name Montanov 68 by the company Seppic, under the name Tegocare CG90 by Goldschmidt and under the name Emulgade KE3302 by Henkel, and arachidyl glucoside, for example in the form of a mixture of arachidic and behenic alcohols and arachidylglucoside sold under the name Montanov 202 by the company Seppic. According to one particular embodiment of the invention, the mixture of the alkylpolyglucoside as defined above with the corresponding fatty alcohol may be in the form of a self-emulsifying composition, as described, for example, in WO- A-92/06778.

  Among the other stabilizers of emulsion, the polymers of isophthalic acid or of sulphoisophthalic acid, and in particular the phthalate / sulphoisophthalate / glycol copolymers, for example the copolymer of diethylene glycol / phthalate / isophthalate / 1,4- cyclohexane-dimethanol (INCI name: Polyester-5) sold under the names "Eastman AQ polymer" (AQ35S, AQ38S, AQ55S, AQ48 Ultra) by the company Eastman Chemical.

  In the case of an emulsion, the aqueous phase thereof may comprise a nonionic vesicular dispersion prepared according to known methods (Bangham, Standish and Watkins, J. Mol Biol 13, 238 (1965)). FR 2 315 991 and FR 2 416 008). The compositions according to the invention find their application in a large number of treatments, in particular cosmetics, of the skin, lips and hair, including the scalp, in particular for the protection and / or care of the skin, lips and / or hair, and / or for makeup of the skin and / or lips.

  Another object of the present invention is constituted by the use of the compositions according to the invention as defined above for the manufacture of products for the cosmetic treatment of the skin, lips, nails, hair, eyelashes, eyebrows and / or scalp, including skincare products, sunscreen products and make-up products.

  The cosmetic compositions according to the invention may for example be used as a makeup product.

  The cosmetic compositions according to the invention may for example be used as a skincare and / or sun protection product for the face and / or the body of liquid to semi-liquid consistency, such as milks, more or less unctuous creams, gel-creams, pasta. They may optionally be packaged in aerosol and be in the form of foam or spray.

  The compositions according to the invention in the form of vaporizable fluid lotions according to the invention are applied to the skin or the hair in the form of fine particles by means of pressurizing devices. The devices according to the invention are well known to those skilled in the art and include non-aerosol pumps or "atomizers", aerosol containers comprising a propellant and aerosol pumps using compressed air as a propellant. These are described in US Pat. Nos. 4,077,441 and 4,850,517 (which forms an integral part of the content of the description).

  The aerosol-conditioned compositions in accordance with the invention generally contain conventional propellants such as, for example, hydrofluorinated compounds, dichlorodifluoromethane, difluoroethane, dimethyl ether, isobutane, n-butane, propane and trichlorofluoromethane. They are present preferably in amounts ranging from 15 to 50% by weight relative to the total weight of the composition.

  Concrete but non-limiting examples illustrating the invention will now be given.

  FORMULATION EXAMPLES 1-7 Phase Chemical Name 1 2 3 4 5 6 7 Purified Wood Extract from Totara 0.1 0.5 1 2 5 10 (TOTAROL) Butyl Methoxydibenzoylmethane 2 2 2 2 2 2 2 C12 alkyl benzoate A cetyl alcohol 0.5 0.5 0.5 0.5 0.5 0.5 0.5 Stearic acid 1.5 1.5 1.5 1.5 1.5 1,5 1,5 PEG-100 stearate / stearate 1 1 1 1 1 1 1 qlyceryl Glucoside cetearyl / Alcohol 2 2 2 2 2 2 2 cetearyl Polydimethylsiloxane (350 cst) 0.50 0.50 0.50 0.50 0.50 0.50 0.50 Preservative 1 1 1 1 1 1 1 Glycerol 5 5 5 5 5 5 5 Propylene glycol 5 5 5 5 5 5 B Disodium EDTA 0.1 0.1 0.1 0.1 0 0.1 0.1 Potassium cetyl phosphate 1 1 1 1 1 1 1 Water qsp qsp qsp qsp qsp qsp 100 100 100 100 100 100 100 xanthan gum 0.2 0.2 0.2 0.2 0, 0.2 0.2 0.2 C Copolymer acrylates / acrylate 0.2 0.2 0.2 0.2 0.2 0.2 0.2 of C10-30 alkyl Isohexadecane 1 1 1 1 1 1 1 D Triethanolamine qs qsp qsp qsp qsp qsp qsp pH pH pH pH pH pH The formulations 1 to 7 are prepared according to the op mode Eratory below; the amounts are indicated in percentages by weight relative to the total weight of the composition.

  Procedure The fatty phase (A) is heated to 70 ° C. The aqueous phase (B) is heated in the final beaker. Phase (C) is prepared: dispersion of the powders in the oil. With Rotor Stator stirring, the fatty phase is emulsified in the aqueous phase. The phase (C) is introduced under stirring more rapidly then it is allowed to stir slowly until it returns to ambient temperature. We neutralize (D). Then we condition.

  Measurement method for photostability

  For each formula, 4 test samples and 4 control samples were prepared. Spatula is deposited with 2 mg / cm 2 of formula on polymethyl methacrylate plates. The test plates are exposed for 46 minutes to SUN TEST HERAUS equipped with a 50 Xenon lamp having a UV-A flux of 7.9 × 10 -3 W / cm 2 and a UV-B flux of 3.8 × 10 -4 W / cm 2. The control plates are stored for the same time and at the same temperature (38-40 ° C) in the dark. At the end of this time, the filters are extracted by immersing each plate in 50 g of ethanol and subjecting them to ultrasound for 15 minutes to ensure good extraction. The solutions obtained are analyzed by UV spectrophotometry.

  For each formula tested, the level of residual 4-tert-butyl-4'-methoxy-dibenzoylmethane after exposure is given in the ratio of its optical density (OD) in the sample exposed to its unexposed optical density (OD). The maximum absorption corresponds to butylmethoxydibenzoylmethane: Xmax = 358 nm.

  The results obtained are summarized in the following table: Compositions 0/0 in residual weight of dibenzoylmethane after exposure 1 hour Solar UVA Formula 1 26.2% without purified extract of Totara wood Formula 2 32.7% 0.1% Extract Formula 3 40.5% 0.5% Extract Formula 4 58.2% 1% Extract Formula 5 68.4% 2% Extract Formula 6 83.6% 5% Extract Formula 7 96 , 1% 10% of extract An improvement in the photostability of dibenzoylmethane is observed in the presence of the said extract containing Totarol.

Claims (28)

  1. Composition comprising in a cosmetically acceptable support at least one UV filtering system, characterized in that it comprises at least: (a) at least one UV-A filter of the dibenzoylmethane derivative type and (b) at least one compound phenanthrénol of formula (I) R, (I) wherein: R, R2 and R6 denote, independently of one another, a group selected from H, OH, a linear alkyl group C1-C4, a group C 3 -C 4 branched alkyl, a radical -OR with R being a C 1 -C 3 alkyl radical, with the proviso that one of the groups R 1, R 2 or R 6 is an OH group and another of the groups R 1, R 2 and R R6 is a C1-C4 linear alkyl group or a branched C3-C4 alkyl group; R3i R4 denote, independently of one another, a C1-C3 alkyl group, preferably a methyl group; R5 denotes a C1-C6 alkyl group, preferably a C1-C3 alkyl group, and preferably a methyl group, as well as their stereoisomers, and diastereoisomers, and mixtures thereof. 20   2. Composition according to claim 1, wherein the compound of formula (I) is chosen from those for which R3i R4 denote a methyl group; R5 denotes a C1-C3 alkyl group. 25   3. Composition according to claim 1, wherein the compound of formula (I) is chosen from those for which R3i R4 and R5 denote a methyl group.   4. Composition according to any one of the preceding claims, wherein the compound of formula (I) is chosen from those for which R1, R2 and R6 are each different and denote, independently of one another, a selected grouping from ,H, OH, a branched C3-C4 alkyl group; R3, R4 and R5 denote a methyl group.   5. Composition according to any one of the preceding claims, wherein the compound of formula (I) is chosen from those for which RI is hydrogen, R2 denotes OH; R6 is isopropyl; R3i R4 and R5 denote a methyl group.   6. Composition according to any one of the preceding claims, wherein the phenanthrenol compounds of formula (I) are chosen from: - 4b, 5,6,7,8,8a, 9,10-octahydro-4b, 8,8 trimethyl-1- (1-methylethyl) -, (4bR, 8aR) -rel- 2-40 Phenanthrenol - 4b, 5,6,7,8,8a, 9,10-octahydro-3-methoxy-4b, 8,8-trimethyl-2- (1-methylethyl) -, (4bS-trans) -1-phenenanthrenol - the 4b, 5,6,7,8,8a, 9,10-octahydro-4b, 8,8- trimethyl-2- (1-methylethyl) -, (4bS, 8aS) -1-phenenanthrenol 45 - 4b, 5,6,7,8,8a, 9,10-octahydro-4b, 8,8-trimethyl-1 (1-methylethyl) -2-phenenanthrenol-3-ethyl-4b, 5,6,7,8,8a, 9,10-octahydro-4b, 8,8-trimethyl-1- (1-methylethyl) - (4bS, 8aS) -4b, 5,6,7,8,8a, 9,1-O-octahydro-3-methoxy-4b, 8,8-trimethyl-1- (1-methylethyl) -, trans-2-Phenanthrenol - 4b, 5,6,7,8,8a, 9,10-octahydro-4b, 8,8-trimethyl-3- (1-methylethyl) -, (4bS, 8aS) -2- Phenanthrenol 15 - 4b, 5,6,7,8,8a, 9,10-octahydro-1-methoxy-4b, 8,8-trimethyl-2- (1-methylethyl) -, (4bS-trans) - 3-Phenanthrenol - 4b, 5,6,7,8,8a, 9,10-octahydro-4b, 8,8-trimethyl-2- (1-methylethyl) -3-phenenanthrenol 4b, 5,6,7,8 8a, 9,10-octahydro-4b, 8,8-trimethyl-1- (1-methylethyl) -, cis-3-Phenanthrenol - 4b, 5,6,7,8,8a, 9,10-octahydro -4b, 8,8-trimethyl-2- (1-methylethyl) -, (4bR, 8aR) -rel-3-phenenanthrenol - 4b, 5,6,7,8,8a, 9,10-octahydro-4b 8,8-trimethyl-2- (1-methylethyl) -, (4bS, 8aS) -3-phenenanthrenol, 4b, 5,6,7,8,8a, 9,10-octahydro-2-methoxy- 4b, 8,8-trimethyl-1- (1-methylethyl) -, (4bS-trans) -3-phenenanthrenol - 4b, 5,6,7,8,8a, 9,10-octahydro-3,4b, 8,8-tetramethyl-1- (1-methylethyl) -, (4bS, 8aS) -2-phenenanthrenol - 4b, 5,6,7,8,8a, 9,10-octahydro-4b, trimethyl-2- (1-methylethyl) -, trans-1,3-phenanthrene diol - 4b, 5,6,7,8,8a, 9,10-octahydro-4b, 8,8-trimethyl-2- ( 1-methylethyl) -, (4bS, 8aS) -1,3-Phenanthrenediol - 4b, 5,6,7,8,8a, 9,10-octahydro-4b, 8,8-trimethyl-1- (1- methylethyl) -, (4bS, 8aS) -2,3-Phenanthrenediol 35 - 8,11,13-trien-12-ol, 14-isopropyl-Pod ocarpa - 4b-hexyl-4b, 5,6,7,8,8a, 9,10-octahydro-8,8-dimethyl-2- (1-methylethyl) -, (4bS-trans) -3-phenenanthrenol 4b, 5,6,7,8,8a, 9,10-octahydro-8,8-dimethyl-2- (1-methylethyl) -4b-pentyl-, (4bS-trans) -3-phenenanthrenol 40- 4b-butyl-4b, 5,6,7,8,8a, 9,10-octahydro-8,8-dimethyl-2- (1-methylethyl) -, (4bS-trans) -3-phenenanthrenol - 4b, 5,6,7,8,8a, 9,10-octahydro-8,8-dimethyl-2- (1-methylethyl) -4b-propyl-, (4bS-trans) -3-phenenanthrenol - 4b-ethyl- 4b, 5,6,7,8,8a, 9,10-octahydro-8,8-dimethyl-2- (1-methylethyl) -, (4bS-trans) -3-45 Phenanthrtenol   7. Composition according to any one of the preceding claims, wherein the compound of formula (I) is chosen from - 4b, 5,6,7,8,8a, 9,10-octahydro-4b, 8,8-trimethyl 1- (1-Methylethyl) -, (4bR, 8aR) -rel- 2-50 Phenanthrenol - 4b, 5,6,7,8,8a, 9,10-octahydro-4b, 8,8-trimethyl- 2- (1-methylethyl) -, (4bS, 8aS) -1-Phenanthrenol - 4b, 5,6,7,8,8a, 9,10-octahydro-4b, 8,8-trimethyl-1 - (1 2-Phenanthrenol - 4b, 5,6,7,8,8a, 9,10-octahydro-4b, 8,8-trimethyl-1- (1-methylethyl) -, (4bS, 8aR) - 2-55 Phenanthrenol 2-Phenanthrenol 2- - 4b, 5,6,7,8,8a, 9,10-octahydro-4b, 8,8-trimethyl-1- (1-methylethyl) -, (4bS, 8aR) ) - Phenanthrenol (4bS - 4b, 5,6,7,8,8a, 9,10-octahydro-3-methoxy-4b, 8,8-trimethyl-1- (1-methylethyl) -, trans) - 2-Phenanthrenol - 4b, 5,6,7,8,8a, 9,10-octahydro-4b, 8,8-trimethyl-3- (1-methylethyl) -, trans-2-phenenanthrenol (4bS, 8aS) 4b, 5,6,7,8,8a, 9,1-O-octahydro-4b, 8,8-trimethyl-1- (1-methylethyl) -, phenenanthrenol (4bR, 8aR) -3- - the 4b, 5,6,7,8,8a, 9,10-octahydro-4b, 8,8-trimethyl-2- (1-methylethyl) -, phenenanthrenol 4b, 5,6,7,8,8a, 9,10-octahydro-4b, 8,8-trimethyl-3- (1-methylethyl) -, (4bS, 8aS) -2-phenenanthrenol - 4b, 5,6,7,8,8a, 9,10- octahydro-4b, 8,8-trimethyl-3- (1-methylethyl) -, trans-2-phenenanthrenol - 4b, 5,6,7,8,8a, 9,1-octahydro-4b, 8,8 trimethyl-1- (1-methylethyl) -, (4bS, 8aS) 2-Phenanthrenol - 4b, 5,6,7,8,8a, 9,10-octahydro-4b, 8,8-trimethyl-2- (1-methylethyl) -, (4bR, 8aR) - 3-Phenanthrenol - 4b, 5,6,7,8,8a, 9,10-octahydro-4b, 8,8-trimethyl-2- (1-methylethyl) ) -3-Phenanthrenol - 4b, 5,6,7,8,8a, 9,10-octahydro-4b, 8,8-trimethyl-1 - (1-methylethyl) -, cis-3-Phenanthrenol - 4b 5,6,7,8,8a, 9,10-octahydro-4b, 8,8-trimethyl-2- (1-methylethyl) -, (4bR, 8aR) -rel-3-phenenanthrenol - 4b, 5b , 6,7,8,8a, 9,10-octahydro-4b, 8,8-trimethyl-2- (1-methylethyl) -, (4bS, 8aS) -3-Phenanthrenol - 4b, 5,6,7 8,8a, 9,10-octahydro-3,4b, 8,8-tetramethyl-1 - (1-methylethyl) -, (4bS, 8aS) -2-Phenanthrene ol - 8,11,13-trien-12-o1,14-isopropyl-Podocarpa   8. Composition according to any one of the preceding claims, wherein the compound of formula (I) is chosen from - 4b, 5,6,7,8,8a, 9,10-octahydro-4b, 8,8- trimethyl-1- (1-methylethyl) -, (4bR, 8aR) -rel-2-phenenanthrenol - 4b, 5,6,7,8,8a, 9,10-octahydro-4b, 8,8-trimethyl- 1 - (1-methylethyl) -2-phenenanthrenol - 4b, 5,6,7,8,8a, 9,10-octahydro-4b, 8,8-trimethyl-1 - (1-methylethyl) -, (4bS 4a, 5,6,7,8,8a, 9,1-O-octahydro-4b, 8,8-trimethyl-1- (1-methylethyl) -, (4bS, 8aS) -2-Phénanthrénol   9. A composition according to any one of claims 1 to 8, wherein the compound of formula (I) is 4b, 5,6,7,8,8a, 9,10-octahydro-4b, 8,8-trimethyl- 1 - (1-methylethyl) -, (4bR, 8aR) -rel-2-phenenanthrenol of the following structure (I '): (l')   10. Composition according to any one of claims 1 to 9, wherein the phenanthrenols compound (s) of formula (I) are present in a content ranging from 0.05% to 30% by weight, relative to the total weight of the composition. and preferably from 0.1 to 20% by weight.   11. Composition according to claim 10, wherein the dibenzoylmethane derivative is 4- (tert-butyl) -4'-methoxy dibenzoylmethane or butyl methoxy dibenzoylmethane of the following formula: 40OMe   12. Composition according to any one of the preceding claims, wherein the dibenzoylmethane derivative (s) are present at contents ranging from 0.01 to 10% by weight and more preferably from 0.1 to 6% by weight relative to total weight of the composition.   13. The composition as claimed in any one of the preceding claims, characterized in that it additionally contains other water-soluble or fat-soluble organic or inorganic active or UV-A photoprotective agents and / or UV-B agents. insoluble in commonly used cosmetic solvents.   The composition of claim 13, wherein the complementary organic photoprotective agents are selected from anthranilates; cinnamic derivatives; salicylic derivatives, camphor derivatives; benzophenone derivatives; 13,13-diphenylacrylate derivatives; triazine derivatives; benzotriazole derivatives; benzalmalonate derivatives; benzimidazole derivatives; imidazolines; bis-benzoazolyl derivatives; p-aminobenzoic acid derivatives (PABA); methylene bis (hydroxyphenyl benzotriazole) derivatives; benzoxazole derivatives; filter polymers and silicone filters; dimers derived from α-alkylstyrene; 4,4-diarylbutadienes and mixtures thereof.   15. Composition according to Claim 14, characterized in that the organic UV screening agent (s) is (are) chosen from the following compounds: Ethylhexyl Methoxycinnamate Homosalate Ethylhexyl Salicylate, Octocrylene, Phenylbenzimidazole Sulfonic Acid, Benzophenone-3, Benzophenone-4, Benzophenone-5, 2 - (4-diethylamino-2-hydroxybenzoyl) -benzoate n-hexyl. 4-Methylbenzylidene camphor, Terephthalylidene Dicamphor Sulfonic Acid, Disodium Phenyl Dibenzimidazole Tetrasulfonate, Methylene bis-Benzotriazolyl Tetramethylbutylphenol Ethylhexyl Triazone, Bis-Ethylhexyloxyphenol Methoxyphenyl Triazine Diethylhexyl Butamido Triazone, 2,4,6-Tris (4'-amino benzalmalonate Dineopentyl) 2,4,6-tris- (4'-amino benzalmalonate diisobutyl) -s-triazine. 2,4,6-tris (biphenyl-4-yl-1,3,5-triazine) 2,4,6-tris (terphenyl) -1,3,5-triazine Drometrizole Trisiloxane Polysilicone-15 Di-neopentyl 4'-methoxybenzalmalonate 1,1-dicarboxy (2,2'-dimethyl-propyl) -4,4-diphenylbutadiene 2,4-bis- [5-1 (dimethylpropyl) benzoxazol-2-yl- (4-phenyl) - imino] -6 (2-ethylhexyl) imino-1,3,5-triazine and mixtures thereof.   16. Composition according to Claim 13, characterized in that the complementary inorganic photoprotective agents are metallic oxide pigments, coated or not.   17. The composition as claimed in claim 16, characterized in that said pigments are chosen from titanium oxide, zinc oxide, iron oxide, zirconium oxide, cerium oxide and mixtures thereof, coated or uncoated.   18. Composition according to any one of the preceding claims, comprising at least one additional light-stabilizing agent for dibenzoylmethane derivatives.   19. The composition of claim 18, wherein the one or more light stabilizing agents are selected from (1) arylalkyl benzoate compounds; (2) amidated oils; (3) eutectic mixtures of n-butylphthalimide and isopropylphthalimide; (4) compounds capable of accepting the triplet excited level energy of said dibenzoylmethane derivative (5) 1,1,3-tri- (2-methyl-4-hydroxy-5-tert-butylphenyl) -butane ; (6) siloxane phenol or bis-phenol compounds (7) non-silicone phenol or bisphenol compounds (8) non-silicone amides or arylalkyl esters (9) siloxane arylalkyl amides or esters (10) their mixtures.   20. The composition according to claim 19, wherein the arylalkyl benzoate compounds are chosen from those of formula (II) wherein X denotes O, S or N; n is an integer of 1 to 10 and more preferably of 2 to 6; R 1 and R 2, which may be identical or different, denote a hydrogen atom; the hydroxyl group; a linear or branched C1-C4 alkoxy radical (preferably methoxy or ethoxy); the nitro radical; the amino radical; the radical C6H6SO2.   21. The composition according to claim 20, wherein the arylalkyl benzoate compound is 2-ethylphenyl benzoate of structure:   22. The composition according to claim 19, wherein the amidated oils are chosen from those of formula (IIIa) or (IIIb) wherein R3 represents a monovalent hydrocarbon radical, saturated or unsaturated, aliphatic, cycloaliphatic or cyclic, optionally functionalized, containing from 1 to 30 carbon atoms, preferably from 1 to 22 carbon atoms, inclusive; the radicals R4, R5 and R6, which may be identical or different, represent hydrogen or monovalent, saturated or unsaturated, aliphatic, cycloaliphatic or cyclic hydrocarbon radicals, optionally functionalized, containing from 1 to 30 carbon atoms, preferably from 1 to at 22 carbon atoms, inclusive; gestator from 0 to 2;   23. A composition according to claim 22, wherein the amidated oils are chosen from (1) N-acetyl N-butylaminopropionate (2) N-lauroylsarcosinate isopropyl (3) N, N-diethyl-toluamide   24. A composition according to claim 19, wherein the eutectic mixture according to the invention is preferably composed of: (a) 60 to 75% by weight of n-butyphthalimide of the following structure (2): (CH2) 3 -CH3 (2) O (b) 25 to 40% by weight of isopropylphthalimide according to the invention corresponds to the following structure (3): O (CH 3) C -OR (3)   25. The composition according to claim 19, wherein the compound (s) capable of accepting the triplet excited level energy of said dibenzoylmethane derivative are chosen from: naphthalene derivatives; 4-hydroxy-benzylidene malonate derivatives or 4-hydroxy-cinnamate derivatives; fluorene derivatives; piperidinol salts; - their mixtures.   26. The composition of claim 25, wherein the naphthalene derivative is diethylhexyl 2,6-naphthalate.   27. A composition according to claim 25, wherein the 4-hydroxy-benzylidene malonate derivative is Diethylhexyl Syringylidenemalonate of the following formula: where t = 1 and u is a number from 2 to 10. 29. The composition of claim 25, where the piperidinol salt is the compound Tris (tetramethylhydroxypiperidinol) citrate structure: HO O OMe   28. The composition according to claim 25, wherein the fluorene derivative is the polymer of the following structure: y = 330. The composition according to claim 19, wherein the phenol compounds or Siloxane bisphenols are chosen from those corresponding to the following general formula (IV) or (V): ## STR2 ## a) / 2 (R) to 15 (V) in which: R7, which may be identical or different, denote hydrogen, a C1-C4 alkyl radical or two adjacent R7 may together form a C5-C7 ring, R8 denotes: a hydrogen atom; a linear or branched C1-C20 alkyl radical which may contain at least one substituent chosen from a C5-C7 carbon cycle, an oxygen, nitrogen, sulfur or silicon atom; ; a C 1 -C 20 alkenyl radical; Alkyl radicals C1-C20, R9, which may be identical or different, represent a C1-C20 alkoxy radical which may be substituted by at least one oxygen or silicon; linear or branched C1-C20 alkyl or hydroxyalkyl which may contain at least one substituent selected from a C 5 -C 7 carbon ring, an oxygen, nitrogen, sulfur or silicon atom; a C 1 -C 20 alkenyl radical; a C 7 -C 20 alkylaryl radical, optionally substituted on the aryl part by at least one hydroxyl or C 1 -C 4 alkoxy, two adjacent R 9 radicals can together form a C 5 -C 7 ring optionally substituted by at least one atom; oxygen, m is 0.1 or 2, n is 0, 1, 2 or 3, pest or 1, A is the linker between the 2 aromatic rings and may be a direct link, a methylene group, mono- or di -substituted by a C1-C4 alkyl radical, a sulfur atom or an oxygen atom; with the proviso that when p = 1, R7 and R8 are different from hydrogen and R9 in the ortho position with respect to the OH function, then R9 is different from a ter-alkyl radical (for example ter-butyl). 45 R, which may be identical or different, represent a linear or branched and optionally halogenated C 1 -C 20 alkyl radical, a C 6 -C 12 aryl radical, 3,3,3-trifluoropropyl, trimethylsilyloxy or a C 1 -C 10 alkoxy group a = 0 to 3, B is a divalent radical chosen from the group corresponding to one of the following formulas (VI), (VII) or (VIII): ## STR2 ## where: ## STR2 ## in which: Z is a linear or branched, saturated or unsaturated C1-C6 alkylene radical optionally substituted with a hydroxyl radical or a linear or branched, saturated or unsaturated C1-C8 alkyl radical; hydrogen, a hydroxyl radical or a linear or branched, saturated or unsaturated C 1 -C 6 alkyl radical, or in addition to the units of formula -B 2 (Si) (R) a (O) (3a) The organosiloxane may comprise units of formula (R) b- (Si) (O) (4-b) / 2 in which: R has the same meaning as in formulas (IV) and (V), b = 1 2 or 3, 31. The composition according to claim 30, wherein the groups û (Si) (R) a (O) (3a) / 2 may be represented by the following formulas (IX) or (X): (VIII) RR io io (D) ùSiûO-SiûO Rio RioR R io io r SiùO-Siù (D) (C) Rio (X) or Rio Rio_ OSi] t [O-Si Rio (E) in which: (E) is a binder between the silicone chain with the group B of the phenols of the formulas (IV) to (V), R10, which are identical or different, are chosen from linear or branched C1-C20, phenyl, 3,3,3-trifluoropropyl and trimethylsilyloxy alkyl radicals, at least 80% by number of the radicals R10 being methyl, (D), which are identical or different, are chosen from the radicals R10 and the radical (E), u is an integer between 0 and 200 inclusive, and s is a an integer between 0 and 50 inclusive, and if s = 0, at least one of the two symbols (D) denotes B, u is an integer between 1 and 10 inclusive, and t is an integer between 0 and 10 inc advantageously, provided that t + u is equal to or greater than 3, with the proviso that when q is 1, then u is 1, s is 1 and the symbol (D) can not denote B or s is 0 and only one of the symbols (D) denotes B. 32. A composition according to claim 30 or 31, wherein the compounds of formula (IV) are chosen from the following compounds of formulas (a) to (n): ## STR1 ## Si-O-Si-O-Si-O-Si-OS (OH) (OH) (OH) (OH) (1) HO (k) ùSiùO + iiùO] m [iiùO n statistic = 6 m statistic = 6 (i) ùSiùO + iùO] m [SiùO n statistic = 2.1 m statistic = 12.5 HO (m) (n) 33. The composition according to claim 30 or 31, wherein the compounds of formula (V) are selected from the following (o) to (w): ## STR2 ## The composition according to claim 19, wherein the phenol compounds or bisphenol compounds are present in the form of a compound of formula (I). phenols are chosen by those corresponding to the following general formula (XIV) or (XV): (v) OH (XIV) 3 / m (XV) (II) in which: R11, which may be identical or different, denote hydrogen, a C1-alkyl radical; -C4 or two adjacent R 'may together form a C5-C7 ring, R12 denotes: - a hydrogen atom, - a linear or branched C1-C20i alkyl radical may contain at least one substituent selected from a carbon ring in C5-C7, an atom of oxygen, nitrogen, sulfur or silicon; a C 1 -C 20 alkenyl radical; a C 1 -C 20 alkylaryl radical, R 13 1, which may be identical or different, represent a C 1 -C 20 alkoxy radical which may be substituted by at least one oxygen or silicon; a linear or branched C1-C20 alkyl or hydroxyalkyl which may contain at least one substituent chosen from a C5-C7 carbon ring, an oxygen, nitrogen, sulfur or silicon atom; an alkenyl radical; C1-C20; a C 7 -C 20 alkylaryl radical, optionally substituted on the aryl part by at least one hydroxyl or C 1 -C 4 alkoxy, two adjacent R 13 radicals can together form a C 5 -C 7 ring optionally substituted by at least one oxygen atom; m is 0.1 or 2, n is 0, 1, 2 or 3, pest or 1, A is the linker between the two aromatic rings and may be a direct link, a methylene, mono- or di-substituted group. by a C1-C4 alkyl radical, a sulfur atom or an oxygen atom; with the proviso that when p = 1, R 11 and R 12 are different from hydrogen and R 13 in the ortho position with respect to the OH function, then R 13 is different from a ter-alkyl radical. 35. The composition according to claim 34, wherein the compounds of formula (XIV) are chosen from the following compounds (a ') to (I'): ## STR2 ## A composition according to claim 34, wherein the compounds of formula (XV) are chosen from the following compounds (m ') to (z'), (aa), (ab) and (ab): ## STR2 ## The composition according to claim 19, wherein the nonsilicone arylalkyl amides or esters are chosen from those corresponding to general formulas (XVI), (XVII), (XVIII) ## STR2 ## R16 in which - R14 is a linear or branched C1-C4 alkyl radical, -aest0-2, - m is 0-4, - b is 1 or 2, - R15 is H, a linear C1-C20 alkyl, or branched, or the acetyl group, - R16 independently is H or methyl, -pest0-4, -gest0-3, -X is O, NH or NR18, -Y is CH or N, -R And R18 are linear or branched C1-C20 alkyl radicals, (R14) to Y (XVIII) with the following condition for formula (XVIII): if Y = CH, R16 = H, m = 0, p = 2, then a is different from 0 and R14 different from methyl. 38. The composition according to claim 37, wherein the amide compounds of formula (XVI) are selected from the following compounds (a ") to (k"): (f ") 20 (") (k ") 39. Composition according to claim 37, wherein the amide compounds of formula (XVII) are chosen from the following compounds (I ") to (r"): ## STR2 ## A composition according to claim 37, wherein the arylalkyl ester compounds of formula (XVIII) are selected from the following compounds (s ") to (x"): The composition of claim 19, wherein the amide compounds or arylalkyl siloxane esters are selected from those of the following general formula (XXV): ## STR2 ## a (R19) p (XXV) in which -R19 is a linear or branched C1-C4 alkyl radical, -pest0-2, -m is 0-4, -X is ùO- or ùN (R20) - - R20 is H, a linear or branched C1-C20 alkyl, the acetyl group or the group --CH2CH2NH (C = O) Ph, - R, which may be identical or different, represent a linear or branched C1-C20 alkyl radical, a radical C 6 -C 12 aryl, 3,3,3-trifluoropropyl, trimethylsilyloxy or a linear or branched C 1 -C 10 alkoxy group, a = 1-2, B is a divalent radical chosen from the group corresponding to one of the formulas (VI), (VII) or (VIII): ## STR5 ## where: Z is a radical linear or branched C1-C6 alkylene, saturated or unsaturated, optionally substituted with a hydroxyl radical or a linear or branched, saturated or unsaturated C 1 -C 8 alkyl radical, W represents a hydrogen atom, a hydroxyl radical or a linear or branched, saturated or unsaturated C 1 -C 8 alkyl radical; The composition according to claim 41, wherein in addition to the units of the formula -Bu (Si) (R) a (O) (3-a) 2i the organosiloxane may comprise units of the formula (R). b- (Si) (O) (4-b) 2 in which: R has the same meaning as in formula (XXV), b = 2-3, 4043. The composition of claim 41 or 42, wherein the groups (Si) (R) a (O) (3-a) / 2 are represented by the following formulas (XXVI) or (XXVII): R21 R 21 121 121 (D) where [SiO0] [SiO0-Si (D) ) R 21 R 21 (E) R 21 (XXIX) or R 21 R 21 O Si Si LO Si R 21 (E) in which: (E) is a binder between the silicone chain and the group B of the compound of formula (I) as defined previously, R21, identical or different, are chosen from the radicals al C1-C20 linear or branched kyl, phenyl, 3,3,3-trifluoropropyl and trimethylsilyloxy, at least 80% by number of the radicals R3 being methyl, (D), which are identical or different, are chosen from radicals R21 and radical ( E), r is an integer from 0 to 200 inclusive, and s is an integer from 0 to 50 inclusive, and if s = 0, at least one of the two symbols (D) denotes B, u is an integer between 1 and 10 inclusive, and t is an integer between 0 and 10 inclusive, with the proviso that t + u is equal to or greater than 3, with the proviso that when q is 1, then u is equal to 1, s is equal to 1 and the symbol (D) can not denote B or s is equal to 0 and only one of the symbols (D) denotes B. 44. Composition according to any one of claims 41 to 43, wherein the compound (s) of formula (XXV) are selected from the following compounds of formulas (a "') to (k"'): NH Si O- u (XXX) O NH NH ((((((((/ / / / / / / / ù ù ù ù ù ù ù ù ù ù ù ù ù ù ù ù ù ù ù ù ù ù ù ù ù ù (g ") 0 / NHO-S1 / / + (h") OI / / NHsi ---- + Sig NH -Si O Si / \ si! o /! I + O () Si - / Si / - O /! o + O Si - / \ (k1 45. Composition according to any one of Claims 1 to 44, characterized in that it also comprises at least one agent for tanning and / or artificial browning of the skin 46. Composition according to any one of Claims 1 to 45, characterized in that it also comprises at least one adjuvant chosen from fats, organic solvents, ionic or nonionic, hydrophilic or lipophilic thickeners, softeners, humectants, opacifiers, stabilizers, emollients, silicones, anti-foam agents, perfumes, preservatives, anionic surfactants, cationic surfactants , nonionic, zwitterionic or amphoteric, active ingredients, fillers, polymers, propellants, alkalinizing or acidifying agents 47. Composition according to any one of claims 1 to 46, characterized in that it is present in the shape of an emulsion hu ile-in-water or water-in oil. 48. Use of a composition as defined in any one of claims 1 to 47 for the manufacture of products for the cosmetic treatment of skin, lips, nails, hair, eyelashes, eyebrows and / or 49. Use of a composition as defined in any one of claims 1 to 47 for the manufacture of care products for the skin, lips, nails, hair and / or scalp. 50. Use of a composition as defined in any one of claims 1 to 47 for the manufacture of make-up products. 51. Process for improving the chemical stability with respect to the UV radiation of at least one UV-A filter of the dibenzoylmethane derivative type as defined in any one of the preceding claims, characterized by the fact that said dibenzoylmethane derivative is an effective amount of at least one phenanthrenol compound of formula (I) as defined in the preceding claims. 52. Use of at least one phenanthrenol compound of formula (I) as defined in the preceding claims in a composition comprising in a cosmetically acceptable support, at least one derivative of dibenzoylmethane as defined in any one of the preceding claims. in order to improve the effectiveness of said composition vis-à-vis UV-A.